Chem 201804225
Chem 201804225
Chem 201804225
201804225 Review
Chem. Eur. J. 2019, 25, 4590 – 4647 4590 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Abstract: Nonconjugated hydrocarbons, like bicyclo[1.1.1]- manner. In this Review article, recent developments and
pentane, bicyclo[2.2.2]octane, triptycene, and cubane are a usages of these special, rectilinear systems are discussed.
unique class of rigid linkers. Due to their similarity in size Furthermore, we focus on covalently linked, nonconjugated
and shape they are useful mimics of classic benzene moie- linear arrangements and discuss the physical and chemical
ties in drugs, so-called bioisosteres. Moreover, they also fulfill properties and differences of individual linkers, as well as
an important role in material sciences as linear linkers, in their application in material and medicinal sciences.
order to arrange various functionalities in a defined spatial
[a] G. M. Locke, Dr. S. S. R. Bernhard, Prof. Dr. M. O. Senge Scheme 1. Synthesis of BCP according to Wiberg et al.[5]
School of Chemistry, SFI Tetrapyrrole Laboratory
Trinity Biomedical Sciences Institute, Trinity College Dublin
The University of Dublin, 152–160 Pearse Street, Dublin 2 (Ireland)
E-mail: [email protected] Different approaches for the synthesis of substituted and un-
The ORCID identification number(s) for the author(s) of this article can be substituted BCPs are known in the literature.[7] The methods in-
found under: https://doi.org/10.1002/chem.201804225. volve cyclizations, ring-expansions, and ring-contractions.
T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. Today, most chemistry of the BCP scaffold arises from the
This is an open access article under the terms of Creative Commons Attri-
bridged [1.1.1]propellane intermediate 6 by utilizing strain
bution NonCommercial License, which permits use, distribution and repro-
duction in any medium, provided the original work is properly cited and is relief as the main driving force. Usually the generation of the
not used for commercial purposes. reactive [1.1.1]propellane intermediate is carried out according
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4591 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4592 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4593 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4594 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Molecular formula C8 H 8
shape[64, 65] Oh point group
appearance transparent, rhombic crystals[64]
decomposition [8C][66] > 220
density [g cm@3][62] 1.29
heat of formation [kcal mol@1] [67]
144
strain energy [kcal mol@1][68] 161.5
Scheme 9. Eaton and Cole’s synthesis of the cubane core.[53, 57] DIPB = 1,4-di- C@C bond lengths [a][63] 1.571
isopropylbenzene; NBS = N-bromosuccinimide. C@H bond lengths [a][63] 1.109
C1@C4 distance [a][62] 2.72
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4595 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4596 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
skeleton, depending on the substituent present in the 4-posi- The p-MOs of 1,3-diethynylbicyclo[1.1.1]pentane 50 showed
tion.[93] Again, a closer look into the strong 1,3-nonbonding in- a remarkable split of about 0.67 eV and similar effects occurred
teractions between bridgehead carbon atoms is necessary for for the 1,3-dibromo[1.1.1]pentane 51 (0.72 eV) and the extend-
the BCP cage system. As mentioned above, the short inter- ed 3,3’-dibromo-1,1’-bis(BCP) 52 (0.45 eV). These effects are not
bridgehead distance (1.80–1.98 a) leads to repulsion of the as strong as the conjugation effect for butadiene 53 (2.5 eV) or
back lobes of the exocyclic hybrid orbitals, and is considered the homoconjugation effect of norbornadiene 54 (0.86 eV), but
to be a main contributor to the overall strain energy of the still show the good relay effect. Recent measurements and cal-
system.[12, 14] culations even showed the possibility to tweak the orbital-
A very valuable method to illustrate the effects of electronic splitting energy with additional substituents on the carbon
communication between two separated electronic systems is cage, for example, hexafluorination led to further enhance-
photoelectron spectroscopy (PE). According to Koopman‘s the- ment.[99] Quantum chemical calculations for diethynyl[n]staf-
orem the first ionization energy of a molecular system is equal fanes, with 1 , n , 5, predict a long-range interaction of
to the negative energy of the HOMO.[94] The effects of direct 0.04 eV over a distance of 18 a for the longest staffane (n =
interactions (through-space) and mediated interactions via the 5).[100] A further hint for the strong through bond-coupling
s-skeleton (through-bond) can be directly observed in the PE within the BCP-skeleton is shown by electron transmission
spectra. The assignment of the absorption energies to the ac- spectroscopy (ETS) studies done by Schafer et al.[101] They de-
cording molecular orbitals (MO) can be quite challenging, due termined the p*-splitting of the acetylenic p*-orbitals in 1,3-di-
to different effects (Jahn–Teller effect, spin-orbit coupling for ethynylbicyclo[1.1.1]pentane 50 to be 1.1 eV. This results com-
heavy heteroatoms, vibrational fine structure, etc.). However, plement the findings of Gleiter et al.,[98] showing a strong
semiempirical models for molecules consisting of the first and through-bond coupling of the p*-orbitals, facilitated by the s/
second row atoms have been used with great success and are s*-skeleton of the linker.
a helpful tool within the assignment of the MOs. The corre- In conclusion, both spectroscopic methods, PE and ETS, clas-
sponding splitting of the ionization energies with the assigned sified the BCP bridging unit as an excellent mediator for elec-
MOs (DIn) represents the degree of interaction. Initial studies tron transfer, not only for radical cations (PE) but also for radi-
on cubane,[95] cubane derivatives,[96] and BCO derivatives[97] cal anions (ETS). On the other hand, cubanes and BCO would
showed only very small splitting, characteristics for only a very be prime linkers in terms or electronic resistors, since little
feeble interaction of the linked systems. A different picture communication occurs via the s-skeleton. Recent literature
was observed for BCP derivatives. Here a rather strong splitting offers detailed theoretical studies,[102] discussing influences and
of linked systems occurs (Figure 7).[98] consequences of electron-transfer systems containing noncon-
jugated hydrocarbon linkers, but little experimental data.
Compound Heat of combustion DHc Heat of formation DHf Strain energy[15] Strain energy per C@C bond
[kcal mol@1] [kcal mol@1] [kcal mol@1] [kcal mol@1]
cyclopropane (C3H6) 505.8[106] 12.7[106] 27.7[15] 9.1
cyclobutane (C4H8) 656.0[92] 6.8[107] 26.3[15] 6.6
cyclohexane (C6H12) 943.8[108] 29.8[108] 0.4[15] 0.1
BCP (C5H8) N/D[a] 51 (calcd)[109] 68.0[15] 11.3
cubane (C8H8) 1155.2[67] 142.7[67] 161.5[68] 13.5
BCO (C8H14) 1195.5[110] 23.6[110] 7.4 0.8
triptycene 2409.1[111] 76.8[111] 7.0[111] 0.8
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4597 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4598 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Strictly speaking, Equation (1) is only valid for localized Figure 11. a) Hyperconjugative delocalization; b) definition of dihedral angle
anions and radicals, and resonance delocalization only plays a V.
minor role in stabilizing these intermediates.[139] In general, the
acidities and bond dissociation energies of hydrocarbons are
influenced by the hybridization of the according orbital. The bridgehead carbon atoms lead to high-energy bridgehead al-
higher the s-character, or the J(C@H), the higher the kinetic acidi- kenes (anti-Bredt[142] alkenes). Consequently, the reduced steric
ty of the hydrocarbon (low values of DHa) (Figure 10). shielding of the exposed bridgehead radicals, in combination
This can be seen in the high kinetic acidities of BCP 60 and with the alleviated hyperconjugation, results in a much higher
cubane 37. The high s-character increases the acidity, as seen reactivity in comparison to “normal” tertiary carbon radicals.[143]
when compared to BCO 10, CP 58, and tBu 59. But due to the But despite their high reactivity, the half-lives for all bridge-
higher transannular interaction between the back lobes of the head-radicals are long enough to study their properties with
bridgehead carbon orbitals, the effect for BCP is partly mitigat- spectroscopic methods.
ed. This effect can be illustrated by adding an electronegative The highest hyperconjugation of the b-hydrogen atoms is
substituent, for example, chlorine, at position 3 of BCP. The en- observed for a parallel orientation to the SOMO (dihedral
ergetically low-lying s* orbitals of the halogen–carbon bonds angle V = 08). The strength of this effect can be seen in EPR
can be populated, leading to a longer carbon–halogen spectra in the hyperfine splitting (hfs) (Figure 12). A significant
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4599 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Scheme 14. The two rearrangement pathways for the cubane radical cation.
Figure 12. Rate of formation and EPR data.[144, 146, 149, 150]
Scheme 13. Allowed radical rearrangement of BCP. Scheme 15. Thermal isomerization of BCP and cubane.
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4600 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4601 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
even more remarkably, Eaton et al. could show with 13C-label- tions (Scheme 23). A similar mechanism was observed under
ing that the homocubene 84 rearranges reversibly to the ho- pure thermal conditions and at elevated temperatures during
mocubylidene 85.[164] Further studies on the equilibrium be- Grubbs-metathesis.[170] The final product after a cascade of cy-
tween the homocubene and the homocubylidene were con- cloreversions and cycloadditions is the stable 4-vinyl-trans-b-io-
ducted by Chen et al. and the equilibrium constant was as- dostyrene 103.
signed to be close to unity at room temperature.[165]
Certain other reaction conditions are able to crack the kinet-
ically stable cubane framework. In the presence of palladium-
on-charcoal Stober et al. observed a stepwise hydrogenation
of the strained skeleton.[166] The scission of the first ring leads
to the secocubane 86. Every further hydrogenation step, from
secocubane to nortwistbrendane 87 and from nortwistbren-
dane to BCO 10, releases about 50 kcal mol@1 of strain energy
(Scheme 20).[167] The order of hydrogenation proceeds as ex-
pected; the least stable/the longest bond is hydrogenated
first.
The presence of an anionic charge at the carbon atom vici- 4.2. Functionalization of bridgehead linkers
nal to the cubane skeleton 89 leads to degradation of the ring
4.2.1. BCP chemistry
system 90. Deprotonation at the a-position of an acceptor
system 88 a or 88 b results in the two diene products 92 and A general approach for the functionalization of BCP utilizes the
93 (Scheme 21).[168] A similar instability is observed for cubyl- reactivity of the internal bond in [1.1.1]propellanes 6. This
bond can be opened either by an anionic, radical, or a cationic
pathway. Generally the cationic pathway leads to ring opening
of the BCP scaffold (Scheme 24), while in the case of
cubane,[59–61] BCO,[26] and triptycene no chemistry of the inter-
nal bond is utilized.
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4602 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4603 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4604 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
combination of BCOC and BrC results in the desired product. A popular and versatile method has arisen that allows for
Moreover, the use of aluminum foil and a catalytic amount of the attachment of a variety of different functional groups di-
bromine in methyl iodide allows for the efficient conversion to rectly to many of the bulky alkyl groups of interest in this
1,4-diiodoBCO 125 b, whereas Fenton conditions enable the review, that is, BCP, BCO, and cubane. These methods, as devel-
FGI to the 1,4-dihydroBCO species 126. Friedel–Crafts arylation oped by Baran’s group involve the cross-coupling of redox-
reactions have also be utilized to access 1,4-diaryl BCO 127 active esters, derived from alkyl carboxylic acids, with organo-
compounds from 1,4-dibromo BCO 125 through the use of metallic species and employ single-electron transfer to achieve
AlCl3 and the chlorinated aryl group.[191] the desired coupled compounds (Scheme 28). The mechanism
4-Methoxy BCO-1-carboxylic acid 128 was utilized to access for the majority of these reactions involves a single-electron-
a series of difluoroethylene BCOs 130 a–j.[192] Several different transfer (SET) mechanism, which circumvents the need for oxi-
functional-group interconversion reactions were performed at dative addition of a transition-metal into the carbon–halogen
the bridgehead carbon atom of BCO to access groups, such as bond, which can often be detrimental for the stability of the
NO2, CN, CF3, COOCH3, F, Cl, OCH3, C6H5, CH3, and C(CH3)3 strained alkyl groups under discussion.
129 a–j. Following this the carboxylic acid moiety, at the oppo- The alkyl redox-active ester 136 has been shown to success-
site bridgehead carbon atom, was reduced and subsequently fully couple with organozinc and organomagnesium species
oxidized to the corresponding aldehyde to allow for the final using an Fe-based catalyst system, such as [Fe(acac)3] (acac =
reaction with LiCF2P(O)(OC2H5)2 thus enabling access to a series acetylacetone) and the dppBz ligand to attach phenyl groups
of 1,1-difluoro-2-(4-substituted-bicyclo[2.2.2]oct-1-yl)ethenes to cubane 137, BCO 137 a, and BCP 137 b;[196] while the forma-
130 a–j. tion of alkyl boronic acids and esters can also be achieved
Another example of BCO chemistry uses 1-bromoBCO 131 a through the use of the alkyl redox-active esters. The catalytic
in direct reductive cross-coupling reactions with allylic acetates system of NiCl·6 H2O and MgBr2·OEt2 is employed to couple
through the use of a CoBr2/Mn catalyst system and an acetoni- the redox-active ester with lithiated bis(pinacolato)diboron.[197]
trile/pyridine solvent mixture. A variety of compounds includ- The boronic acid can then be accessed by reacting the ester
ing 1-allyl BCO 132 were synthesized through this method in product with boron trichloride. This method was successfully
reasonable yields within 4–6 h.[193] The BCO scaffold was suc- applied to synthesize methyl 4-(pinacolboron)cubane-1-carbox-
cessfully alkylated from 1-bromo-4-methyl BCO 131 b by using ylate 138 and methyl 4-(pinacolboron)BCO-1-carboxylate
the corresponding Grignard reagent to synthesize 1-methyl-4- 138 a.
pent-1-yl BCO 133.[194] Similarly, Friedel–Crafts alkylation was On the other hand, alkyl boronic acids and esters can also
also employed to alkylate 1-chloro-4-methylBCO 131 c by be produced through photoinduced decarboxylative boryla-
using AlMe3 to form 1,4-dimethyl BCO 134.[192] 4-Methyl-1-(2- tion of carboxylic acids as developed by Aggarwal and co-
phenylethynyl) BCO 135 was synthesized from 1-iodo-4-meth- workers.[198] This method does not use transition-metal catalysis
ylBCO 131 d through reaction with silver(I) phenylacetylide in but instead utilizes light to initiate the radical combination of
anhydrous pyridine under argon at 150 8C in 31 % yield. How- the N-hydroxyphthalimide ester derivative with the diboron re-
ever, these reaction conditions were only successful for this agent bis(catecholato)diboron. This reaction was used with
compound, as attempts to react silver(I) phenylacetylide with both cubane, BCO, and BCP scaffolds 138, 139 a,and 139 b, re-
1,4-diiodoBCO and methyl 4-iodoBCO-1-carboxylate failed.[195] spectively, to form their boronic ester derivatives, in moderate
to good yields.
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4605 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Scheme 29. Examples of organic transformations with cubane and classic cubane carbonyl chemistry. IBDA = iodobenzene I,I-diacetate.
A method for decarboxylative alkynylation was the target of carboxylation mechanism (Scheme 29).[204] This was achieved
further investigations. Again a redox-active alkyl ester was uti- through the use of hypervalent Phl(OAc)2-CCl4-I2 and with irra-
lized to react with either an alkynyl Grignard reagent using an diation of the compound. The iodocubane products were
iron catalyst or a lithiated-alkynylzinc species with a nickel cat- achieved in 80–90 % yields. Phenylcubane 150 was first ob-
alyst. Unfortunately, this approach was not successful for any tained from the transformation of fluorocubane 149, when it is
of the tertiary bulky cagelike alkyl groups 141 in this Review, reacted with benzene and boron trifluoride in toluene in a
that is, those derived from BCP, BCO, and cubane.[199] In addi- Friedel–Crafts type reaction.[205] After 30 min, a 40 % yield of
tion, decarboxylative alkenylation of a variety of groups can be phenylcubane was achieved as the sole product.
used as well. Here, a redox-active alkyl ester is coupled with an Much chemistry has been reported based on work with car-
alkenylzinc reagent in the presence of [Ni(acac)2] and a bipyri- bonyl cubanes. Dimethyl cubane-1,4-dicarboxylate 151 was
dine ligand. Methyl 4-(propen-2-yl)BCO-1-carboxylate 142 was transformed into a variety of different functional groups from
prepared in a 42 % yield through this method.[200] reactions with the ester functional group. Triazole 152 a, oxa-
Most recently, redox active esters have been employed to zole 152 b, thiazole 152 c, imidazole 152 d, pyrazole 152 e,
synthesize sp3-rich(fluoro)alkylated scaffolds.[201] This is made benzimidazol 152 f, pyridine 153 a, isoxazole 153 b, and imid-
possible through modular radical cross-coupling with sulfones azole 153 c functionalities were all introduced through classic
in the presence of [Ni(acac)2] followed by the reaction with (4- carbonyl transformations.[206]
fluorophenyl)zinc chloride. This method was shown to be ap- To access cubane for use in palladium cross-coupling reac-
plicable with the BCO scaffold 143. Copper catalysis and pho- tions a series of chemically distinct, highly strained, activated
toredox catalysis were coupled together to develop a new cubane scaffolds were synthesized (Scheme 30). This was
method to incorporate alkyl substrates by sp3 C@N bond for- achieved by using iodinated cubane derivatives 154 to opti-
mation.[202] This strategy involves the reaction between alkyl mize lithium–halogen exchange reactions.[207] Boron 155 a,
carboxylic acids, such as BCO 144 and BCP 145 (via in situ io- phosphorus 155 b, tin 155 c, silicon 155 d, sulfur 155 e, and
donium activation) and N-nucleophiles. N-BCO and N-BCP alkyl 155 f groups were attached to the cubane scaffold with
products, 146 and 147, respectively, can be achieved in high this method. The optimum conditions found for the metal–hal-
yields at room temperature from 5 to 60 min when irradiated ogen exchange reaction allowed for the generation of the lithi-
with light while activated by an iridium catalyst and in the ated intermediate through the reaction of cubanyl iodide 154
presence of copper. The reaction proceeds via single-electron with two equivalents of tBuLi at @78 8C in THF for 1 h. The re-
transfer pathways and opens a new avenue to C@N bond for- action mixture was then allowed to warm to room tempera-
mations that uses alkyl carboxylic acids over alkyl halides as ture after two equivalents of the relevant R@X reagent were
the coupling partner. Further details of these types of reactions added. These electrophilic cubanes were then investigated for
can be found in the recent review entitled “Decarboxylation as their use in Suzuki–Miyaura, Negishi, and Stille cross-coupling
the key step in C@C bond-forming reactions”.[203] reactions with various halogenated phenyl groups, but all cou-
pling reactions proved unsuccessful.
To avoid transition-metal-facilitated oxidative addition direct-
4.2.4. Cubane chemistry
ly onto the cubane core an ethynyl bond was introduced. So-
Cubanyl chemistry has evolved over the years to increase its nogashira cross-coupling reactions with ethynylcubane 156
applicability in modern day synthesis. Work in the 80s showed and different halogenated aromatic groups proved successful
how a cubanyl carboxylic acid group 47 a could be trans- due to the presence of this spacer. As a result, a variety of
formed to an iodide 148 by a hypervalent iodine oxidative de- ethynyl-linked cubane products were obtained, showing the
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4606 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
first example of cubane stability in the presence of palladium line derivative provided the best results.[208] It was hypothe-
catalysts.[208] Conditions for this reaction were optimized for sized that the ligand affects the rate-determining step of the
the coupling of 1-iodo-4-ethynylcubane 156 a with various catalytic cycle, that is, the reductive elimination of the cubane
halogenated substituted aryl groups. These conditions involve and aryl residue from the nickel center. Yields were achieved of
the reaction of a 0.1 m concentration of cubane 156 a with over 50 % with this method with very electron-rich aryl moie-
three equivalents of the aryl halide, in the presence of ties and unfunctionalized aryl groups that could be coupled
[Pd(PPh3)4] (10 mol %) and CuI (30 mol %) in NEt3 under argon smoothly. This is a two-fold increase over previously reported
for 16 h. The highest yield observed was 90 % when cubane yield of 25 % for the iron-catalyzed coupling.[196] But most excit-
156 a was coupled with ethyl 4-iodobenzoate. Also, the first ingly, the first example of a directly coupled cubanyl porphyrin
ever example of a porphyrin attached to a cubane was achiev- was obtained.
ed with this method under copper-free Sonogashira conditions Additional chemistry with cubane can be observed such as
in a 51 % yield. Sonogashira conditions were also employed for the nickel-catalyzed Barton decarboxylation and Giese radical
coupling reactions of 1,4-diethynylcubane with various por- conjugate addition reactions.[209] These reactions were rein-
phyrins. Monosubstituted products were achieved in yields up vestigated to simplify the required conditions and widen the
to 83 %. scope of the reactions. In each case N-hydroxyphthalimide
The direct attachment of aryl groups, namely porphyrins (NHPI) based redox-active esters were utilized and a thermally
onto the cubane core was still a synthetic target for us, so a initiated Ni-catalyzed radical formation was carried out. Subse-
different approach was sought to achieve this as palladium- quent trapping with either a hydrogen atom source (PhSiH3) or
catalyzed cross-coupling chemistry failed due to the instability an electron-deficient olefin in the case of 159 and 160, respec-
of the cubane core in presence of palladium. A single-electron- tively, led to the two products of interest. The former route re-
transfer mechanism was chosen, as it circumvents the require- sulted in the decarboxylated cubane product in 77 % yield
ment for the oxidative addition of the transition metal onto while the latter route gave the alkylated cubanyl product in
the cubane core by instead utilizing the cubyl radical which is 56 % yield. Additionally, an interrupted Barton decarboxylation
rather stable. Moreover, the versatility of redox-active esters reaction can be used to synthesize simple sulfinate salts 161
used for decarboxylative cubane-aryl cross-coupling had been from readily available carboxylic acids 47 b.[210] The carboxylic
seen by work performed by the Baran group, which supported acid is transformed to acyl chloride, then reacted with 1-hy-
SET as a viable method for cubanyl porphyrin coupling. Firstly, droxypyridine-2-thione, followed by illumination with light,
optimization of the nickel-catalyzed cubane-aryl coupling was then exposure to ruthenium trichloride and sodium periodate
carried out by looking at five major contributing factors: 1) sol- to form the sulfone product. Addition of sodium ethoxide
vent, 2) temperature, 3) concentration, 4) Ni source, and 5) allows for the conversion to the sulfinate salt. The cubanyl sul-
ligand. The ligand was identified as the main contributing pa- fone product was achieved in 42 % and the salt in 95 %.
rameter and results showed that the very electron-deficient
4,4’-functionalized bipyridines, especially the rigid phenanthro-
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4607 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4608 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4609 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4610 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Figure 19. Ru2 + complexes linked by BCO that were used to investigate long-range energy transfer.
energy transfer occurs from the Ru center to the Os center, molecular rotary motor. This concept is based on the transport
shown through observations in which the Ru luminescence is of electrons between two electrodes by electroactive groups
quenched while sensitization of the Os- based luminescence attached to a central rotatable core.[234] The ultimate goal is to
occurs. In the RuOs complex, the critical temperature for when study the molecule between the two electrodes of a nanojunc-
the energy-transfer rates for Ru-based intrinsic deactivation tion to test its applicability as a molecular machine.
and Ru!Os are identical is 184 K. It was found that over the In light-harvesting systems, amongst other electron-transfer
temperature range 90–200 K, the Ru!Os energy transfer rate processes, M(N-N)2n + complexes have become an area of much
in {(ttp)Ru(tpy-ph-bco-ph-tpy)Os(ttp)}4 + is 5.2 V 106 s@1 (20 %). interest, in which M is a second or third transition-row metal
Therefore, energy transfer is neither affected by temperature ion such as RuII, ReI, or OsII.[235] RuII and ReI act as photosensitiz-
changes nor by the state of the solvent, which is fluid at T > ers and are modulated by the donor- or acceptor groups of
110 K and frozen below that temperature. the coordinated N-N ligands, such as 2,2’-bipyridine (bpy) or
To study long-range electron transfer in TiO2 semiconductor 1,10-phenanthroline (phen) (Figure 20).
nanoparticle thin films, a tripodal RuII–polypyridyl complex 179 Different triptycene spacers of varying oxidation states were
was synthesized with a BCO bridge.[231] The BCO moiety was employed to make Ru2 + and Os2 + complexes 182–184, allow-
chosen to investigate the role of conjugation in the bridge. ing the spacer to act as a redox-active switching unit and en-
1,3,5,7-Tetraphenyladamantane derivatives, containing three abling the quinone spacer to potentially control energy and
CO2Me anchoring groups, were used to anchor the molecule electron-transfer reactions in between two complexed metal
to the TiO2 film while the Ru complex with bpy ligands was centers.[236] Key steps in the synthesis of these complexes were
employed as the sensitizer. Sonogashira methodologies were the Diels–Alder reactions to form the triptycene scaffold and
utilized to attach the different moieties to the BCO bridge. the lithium–halogen exchange reactions used to connect the
Through the use of theoretical calculations the role of BCO RuII moieties to the diformyltriptycene. The ratio between the
as an electronic insulator was evaluated by a comparison of relative emission of (Ru-bmb-Ru), (Ru-btb-Ru), and (Ru-bqb-Ru)
the electronic coupling parameter (Vab) of 1,4-bis(ferrocenyl)- was found to be 3.7:2:1. The highest emission was found for
benzene and 1,4-bis(ferrocenyl)BCO 180. DFT was used to opti- the bmb ligand due to the donor effect of the methoxy-sub-
mize geometries and extended Heckel calculations were em- stituents, whereas the lowest emission was seen for the bqb
ployed to calculate Vab by the dimer splitting method. Results system as the emission is strongly quenched by the quinone
of the calculations showed a 12-fold decrease in electronic moiety. Owing to the quinones redox active properties emis-
coupling with the BCO derivative (Figure 20).[232] sion tuning can be obtained. The electronic energy level is
Following this, a potential star-shaped molecular motor 181 positive enough for the quinone moiety, in the metal complex
was synthesized that incorporates the BCO fragment.[233] The Ru–bqb–Os, to act as a quencher for the Ru-based 3CT excited
molecule is based on a ruthenium complex that bears a tripo- state as is shown by the lack of phosphorescence seen from
dal stator functionalized with ester groups to be anchored the Os-based 3CT level.
onto oxide surfaces. These motors contain ferrocenyl electroac-
tive groups and the cyclopentadienyl (Cp) rotor connected
5.2. Porphyrin systems
through the insulating spacer BCO. The known 1,4-disubstitut-
ed BCO is a good candidate, as it has a rigid saturated back- Porphyrins have been employed as more accurate photosyn-
bone enabling it to maintain linearity and rigidity in the arms thetic mimics due to their similarity in structure and electronics
of the motor. This is an example of an electrically fueled, single with the chlorophyll pigments in plants[212] and due to the
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4611 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
many advances in their synthesis, structural understanding, of a semiempirical method. The edge to edge distances of the
and functionalization.[237] In 1984, the first porphyrin photosyn- BCO and biBCO systems 185 and 186 were found to be 10
thetic model with a linear-rigid linker was published. The link and 14 a, respectively. It was predicted in these systems that
between electron tunneling and distance was investigated by hole transfer would dominate, resulting in a significant differ-
extending the length between two chromophores with addi- ence between the rate of decay for the forward electron trans-
tional BCO linkers (Figure 21).[238] Due to the employment of fer compared with that of the reverse electron transfer over
the rigid BCO linker, the dependence of variables such as dis- distance. Results indicate that the symmetry of the donor and
tance, orientation, and the energy gap between donor and ac- acceptor orbitals relative to the BCO linker orbitals determines
ceptor molecules in electron-transfer processes can be more the energy dependence on it to mediate the donor–acceptor
effectively studied. The electronic energy for photosynthetic interactions. Also, for every additional BCO unit added it was
model compounds, linked by BCO, containing a porphyrin and expected that the forward rate from the singlet excited state
quinone unit in 185 and 186, was calculated through the use will slow by a factor of 1500, whereas the reverse rate will only
decrease by a factor of 60.
To effectively mimic photosynthesis, the ability to control
the ratio of the rates for charge separation and recombination
is key in creating long-lived charge separated states, which is
necessary for efficient electron-transfer processes. Marcus
theory was used to further understand these rates in electron-
transfer reactions on a series of electron donor–acceptor sys-
tems with push–pull chromophores as electron acceptors.[239] A
zinc(II) porphyrin (ZnP) electron donor connected via a rigid
phenylene–ethynylene–phenylene (PEP)BCO linker to different
anilino-substituted multicyanobutadienes or extended tetra-
cyanoquinodimethane analogues 187 was synthesized
(Figure 21). First reduction potentials were obtained, and cou-
pled with other results, showed that the extent of ZnP fluores-
cence quenching correlates with the strength of the electron
acceptor. This finding indicates that a rational tuning of the
Figure 21. Monoporphyrin BCO-linked systems as photosynthetic mimics. photophysical properties by the push–pull chromophores as
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4612 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
electron acceptors is possible. The computed Marcus curves To further understand the factors that control the depend-
showed that the charge-recombination kinetics in the inverted ence of ET rates on the distance between the electron-donor
region was greatly affected by enhancing the electron-vibra- and the -acceptor, a series of (ZnII–FeIII) 5,10,15,20-tetraarylme-
tion couplings, due to the conformationally highly fixed push– talloporphyrin dimers 189, with a variety of different linkers, in-
pull acceptor chromophores. X-ray crystal structure data cluding BCO, were synthesized and the kinetics of their PET re-
showed well-defined systems holding the acceptor and donor activity were measured.[241] Through the use of fluorescence
moieties at fixed distances with edge-to-edge distances of lifetime measurements, the electronically excited states of the
around 17 a with little spectral overlap between the porphyrin zinc porphyrin to the bis(imidazole)iron porphyrin cation could
and acceptor moieties. It can be deduced from this data that if be determined. Results showed that when the distance was in-
electron transfer is occurring by a through-bond mechanism creased by 13 a the rate of electron-transfer only decreased by
the likelihood of Fçrster resonance energy transfer is greatly a factor of 165 indicating a small reduction of the electronic
reduced. coupling with distance. Selective nucleophilic aromatic substi-
It is of great interest to generate long-lived ion pair (IP) tution of the para-fluorine atoms in tetra-arylporphyrins was
states via singlet radical ion pair states to effectively mimic effi- employed in the synthesis of the molecular building blocks.
cient charge separation (CS) in a photosynthetic reaction This method allowed for a wide variety of systematic modifica-
center (RC). Strategies based on multicomponent donor–ac- tions such as type and length of spacer, metal center, and
ceptor systems that require multistep electron-transfers offer redox-potential difference between donor and acceptor. A
great possibilities in achieving this goal. With this in mind, con- single zinc(II) or one iron(III) atom can be inserted after the
formationally constrained triads 188 were synthesized consist- synthesis of the symmetrical porphyrin dimer (Figure 23).
ing of a metal-free porphyrin (H2P), a zinc porphyrin (ZnP) and Further studies involving porphyrin-based donor–bridge–ac-
1,4:5,8-naphthalenetetracarboximide (NIm) (Figure 23).[240] The ceptor (D–B–A) systems aimed to find the triplet excited-state
porphyrin moieties are bridged by four different aromatic deactivation of a gold porphyrin (AuP) (Figure 24).[242] 1,4-Di-
spacers one of which is BCO-1,4-diylbis(1,4-phenylene). Pico- ethynyl-BCO was utilized as a saturated linker to explore
second excited-state dynamics were studied with these sys- whether electrons/electron holes can be transferred within the
tems using picosecond time-resolved transient absorption dimer 190 between AuP and ZnP. As a comparison, 1,4-diethy-
spectroscopy. Results showed that long-lived ion pair states of nylbenzene (BB) and 1,4-diethynylnaphthalene (NB) were de-
the triads (ZnP) + -(H2P)-(NIm)@ were observed upon photo-exci- rived as conjugated linkers. The porphyrins are separated by
tation by charge separation between the (H2P)* and NIm fol- 19 a, edge-to-edge, so a direct (through-space) exchange
lowed by a hole-transfer reaction from the (H2P) + to the ZnP. mechanism was not predicted. Results showed no quenching
The rates of this hole transfer were used to determine quan- of AuP that is, no hole transfer, when the conjugation in the
tum yields of the formation of long lived ion-pair states system is broken due to the BCO linker. While long-range hole
(Figure 22). transfer from AuP to ZnP occurs on the nanosecond time scale
at room temperature in the dimers connected by fully-conju-
gated bridging chromophores (NB and BB).
A similar porphyrin scaffold was used to investigate effects
on the photophysical processes in the donor–bridge–acceptor
(D–B–A) systems through studies of the acceptor spin state.[243]
Again, 1,4-diethynyl-BCO, -BB and -NB were the linkers investi-
gated. In this system 191, FeP acts as the acceptor while ZnP
acts as the donor. FeP is modulated from iron(II) to low-spin
iron(III) by the coordination of an imidazole ligand. In previous
such systems, the high-spin FeIIIP significantly enhances the in-
tersystem crossing in the ZnP, as the dominating deactivation
Figure 22. Energy-level diagram of artificial photosynthetic-bisporphyrin
model 188 (ZnP = zinc(II) porphyrin, H2P = free base porphyrin, pathway for the singlet excited zinc porphyrin. But this process
NIm = 1,4:5,8-naphthalenetetracarboximide; cf. Figure 23). is only a minor contribution to the quenching of the low-spin
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4613 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
iron(III); instead the major photophysical process that is occur- as for the construction of supramolecular assemblies and giant
ring is a long-range electron transfer on the picosecond time- molecules. Furthermore, in the last decade, the mechanical
scale allowing intersystem crossing to occur at its “normal” properties of wheels, vehicles, rotors, and motors have been
rate. EPR and UV/Vis measurements were used to prove the vigorously studied. Molecular machines and rotors are seen in
change from iron’s high-spin state to low-spin state upon imid- all living organisms and possess vital roles in many biological
azole coordination. Steady-state and time-resolved fluores- processes from cell division, motility and muscle contraction to
cence measurements were used to measure total quenching supporting cellular metabolism, vesicle and neuronal transport,
efficiencies for the excited states of the zinc porphyrin donors. as well as signaling and energy processing in cellular mem-
Again an analogous porphyrin-based donor–bridge–accept- branes.[245] As a result of the impressive flexibility and efficiency
or (D-B-A) system 192 with a 1,4-diethynyl-BCO spacer was in- observed in these biological nanomachines, much experimen-
vestigated, this time to find out the contributions towards sin- tal effort has been invested to develop artificial molecular de-
glet energy transfer from Fçrster and Dexter mechanisms.[244] A vices that can be used in areas such as medicine, nanotechnol-
clear distinction between the two mechanisms can be seen ogy and material science.
when the inert BCO-linker is used. This so-called superex-
change mechanism for singlet energy transfer has been shown 6.1. Rods
to make a significant contribution to the energy transfer rates
6.1.1. Liquid crystals
in several D–B–A systems and its D–A distance as well as D–B
energy gap dependencies have been studied. In each system, Liquid crystals (LCs) are largely known for their use in LCDs,
the acceptor is a free base porphyrin and the donor consists of namely liquid-crystal displays that are incorporated into many
a zinc porphyrin with/without a coordinated pyridine ligand. everyday electronic devices such as electric wrist-watches. A
Complementary results were obtained for the energy-transfer nematic LC is a transparent liquid that can cause the polariza-
processes in these BCO-bridged porphyrin D–B–A systems with tion of light due to its crystal-like organization, and how much
both experimental and theoretical methods. Results highlight- the light is polarized can in turn be modulated through the ap-
ed that the singlet energy transfer contribution is relatively plication of electric current. LCDs are made from nematic,
similar from both Coulombic (Fçrster) and through-bond su- smectic A or C materials. The LC phases are usually comprised
perexchange mechanisms and that the relative contributions of molecules containing a rigid core with flexible substituents
do not vary with the D–A distance. The distance-dependence to for an extended rod. The mesogenic rigid cores provide the
was shown to be approximately exponential for through-bond anisotropic interactions, required to form the LC state and are
coupling for singlet energy transfer. thought to modulate the properties of the materials while the
substituents lower the melting point of the molecule.[246]
It is rare that thermotropic LC phases are found in single-
6. Applications of Rigid-Linear Linkers in
ring compounds as they often crystallize before forming a
Molecular Rods and Rotors
mesophase. But these compounds, especially with simple alkyl
Aliphatic rigid linkers are seen throughout material chemistry, substituents, are desirable for their potential to reduce the vis-
from areas such as molecular rods and rotors to metal organic cosity of nematic mixtures while not affecting the devices op-
frameworks (MOFs). Molecular rods first became of interest erating range.[247] Additionally, studies with these simplified
due to their applications in electron and energy transfer stud- structures reduce the number of variables so the actual ring
ies, their use in liquid crystals and polymer chemistry, as well effect on mesogenic behavior can be assessed. Simple nonpo-
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4614 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4615 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4616 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4617 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Figure 32. Molecular rods that exhibit restricted rotation along the rod axis.
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4618 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
pounds such as phenanthrene-9,10-epoxide, followed by a de- held together by chemical bonds. The rotator has the smaller
hydration reaction to form the product 227. moment of inertia while the stator has the largest.
Due it its very rigid 3D structure, cubane offers opportunities Hexagonal tris(o-phenylenedioxy)cyclotriphosphazene (TPP)
to make a variety of new materials, including polymers. The was employed as a host to investigate the behavior of dipolar
first cubanyl polymer was achieved by the metathesis polymer- rotor assemblies that acted as guests.[286] A variety of different
ization of the 1,4-bis(homoallyl)cubane 228. Addition of 3,6-disubstituted pyridazines were synthesized including 3,6-
Schrock’s molybdenum catalyst enabled the production of an bis(3-methylbicyclo[1.1.1]pent-1-yl)-
oligomer with an average of 6.2 repeat units per chain pyridazine 232 (Figure 36). It was
(Figure 35).[282] seen that the BCP compound
formed hexagonal bulk inclusion
compounds with TPP and that the
Figure 36. BCP rotor.
in-plane lattice parameters for the
hexagonal phases increased with
the size of the end group, which in
turn controlled the energy barriers for rotation of the pyrid-
azine dipole. Overall it was shown that through a combination
of molecular design and optimal positioning of the rotor mole-
cules in the host material, a dramatic lowering of rotational
barriers can be achieved. Key steps in the synthesis of 232 in-
cluded a Grubbs metastasis reaction to connect the two BCP
moieties by a double bond. The introduction on the pyridazine
ring was achieved by the reaction of hydrazine with the bridg-
ing 1,4-diketone moiety, followed by its subsequent aromatiza-
tion with Pd/C.
Bis{[4-(4-pyridyl)ethynyl]bicyclo[2.2.2]oct-1-yl}buta-1,3-diyne
233 was synthesized containing two 1,4-diethynyl-BCO rotators
Figure 35. Cubane polymers. linked by a diyne fragment (Figure 37). Sonogashira methodol-
ogies were employed to link the BCO and pyridine moieties.[287]
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4619 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4620 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4621 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
should be occurring in gas phase. Rapid rotation was also ob- molecular machines based on amphidynamic crystals with iner-
served also in the solution phase from a dynamically averaged tial rotors.
1
H and 13C NMR spectra. Amphidynamic crystals have strong translational interactions
A convergent synthesis was reported to prepare molecular that are separate from internal rotational motions which are
gyroscopes in which para-phenylene rotors linked by triple thermally activated in the solid-state.[307, 308] The role of intramo-
bonds to methyl-substituted triptycenes act as pivots and en- lecular interactions, vibrations, coupling, and flexibility of dif-
capsulating frames. 1,4-Bis[2-(2,3,6,7,12,13-hexamethyl-10-alkyl- ferent segments were investigated using extensive rigid-body
9-triptycenyl)ethynyl]benzenes 246 were prepared from 2,3-di- molecular dynamics simulations and simple phenomenological
methyl-1,3-butadiene by using Diels–Alder cycloaddition and a arguments. Cubane 249 and BCO 250 analogues with 1,4-trityl
Sonogashira reactions to attach the three units. Different trip- substitutions were model systems (Figure 42).[309] Results sug-
tycenes with methyl, propyl, and benzene substituents at the gest that the flexibility and size of a molecular rotor, alongside
bridgehead C10-position were employed to synthesize a varie- intramolecular interactions within the rotator and stator,
ty of molecular gyroscopes. The best results were observed strongly affect their crystal packing structure, energies and ro-
with small methyl and propyl electron donating substituents tational behavior. Ordered crystalline phases that have speci-
at C10 over the larger benzene group. Also, results suggest for fied free volume for rotations of the central group are seen
free movement around the phenylene axis to occur as low as when there are strong interactions are present in the stator
100 K, illustrating a relatively efficient gyroscopic motion.[303] To segments. Increased flexibility in the stator leads to increased
further improve upon the solubility and dynamic properties of disorder in the system, drastically affecting rotational dynamics
the 1,4-phenylene linked triptycene molecular gyroscopes the due to increased interactions with the local environment. Fur-
unsymmetric triptycenyl-trityl stator 247 was prepared. This thermore, the theoretical results obtained correlate with exper-
compound retains the relatively high melting point of the two imental data that suggested that rotational barriers are gener-
symmetric structures, while achieving the other aforemen- ally larger for less symmetric rotator groups and that electro-
tioned properties. The unsymmetric molecule was synthesized static effects might be not very important.
again through the use of Pd0-catalyzed cross-coupling with
1,4-diiodobenzene.[304] 6.2.3. Molecular gears
The target of amphidynamic crystals (otherwise known as
6.2.3.1. Molecular spur gears
molecular gyroscopes) is to obtain a molecule that rotates
close to its moment of inertia. A molecular rotor with a high The correlated motion of macroscopic mechanical devices can
symmetry order was synthesized with a BCO rotator linked to be mimicked on the microscopic level through designed mo-
rigid mestranol fragments.[305, 306] The compound was synthe- lecular gears that consist of two or more rotators in one mole-
sized in a one-pot, three-step coupling reaction between 1,4- cule. The most widely synthesized gears are spur gears which
diethynyl-BCO and mestrone with perfect diastereoselectivity hold the two rotors parallel to one another at the axes and
and good overall yields. Isomorphous crystals were formed have straight-teeth relative to the axes. For a gearing mimic to
with the benzene derivative of 248, but were not observed for be successful, it is essential to have the gear axes mounted on
the BCO rotator due to disorder in the packing (Figure 42). a rigid base in the same direction. Triptycene is a popular
choice for molecular gearing due to its D3h symmetry, a resem-
blance to a macroscopic gearwheel.
9-(2-Indenyl)-triptycene was dimerized to investigate wheth-
er the free-rotation around the indenyl-triptycene bond that
occurs in the monomer could be affected or inhibited.[310] The
sterically congested size and shape of the dimer 251 deter-
mined the orientation of the triptycene blades (Figure 43). In
the solid state, the C2-symmetry of the whole molecule is
broken due to the intermeshing of the pairs of triple paddle-
wheels and rotation is restricted. In solution C2-symmetry is re-
stored, as seen by the gear-like rapid contra-rotation of the
triptycene paddlewheels when it is dissolved. The racemic
dimer 2,2’-bis(9-triptycenyl)-1,1’-biindenyl 251 was formed
through the lithiation and subsequent oxidation of 9-(2-inden-
Figure 42. Amphidynamic crystals of molecular rotors. yl)triptycene.
Spur gears were synthesized with either an anthracene 252
or naphthalene 253 base and two triptycene rotors connected
NMR experiments showed that the BCO has a relatively low ac- by two acetylene shafts to diminish steric interactions between
tivation energy barrier allowing it to achieve a high average the two moieties. These molecular structures were compared
site exchange rate at ambient temperatures which is notable to investigate the orientation of the two gear shafts and the
due to the large size of BCO. These results suggest the applica- meshing of rotor moieties.[311] Results showed that tuning the
bility of BCO derivatives in ultrafast responsive materials and orientation of the two rotors was possible by varying the base
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4622 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Figure 44. Triptycenyl spur gears with nitrogen-aromatic linkers and a metal-
locene molecular gear.
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4623 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4624 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4625 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
to encapsulate the desired molecules.[326] Rigid organic ligands, reliable formation of the 3D MOF whereas interpenetrated 3D
usually those containing aromatic units or spacers, are em- frameworks have a tendency to form in other rodlike pillaring
ployed in the construction of MOFs, although, as is outlined in ligands such as those containing bipyridine in terephthal-
this section, rigid-aliphatic linkers can also be implemented.[327] ates.[330] Potential applications of this MOF include uses in the
MOFs can be utilized in the pursuit of potential artificial mo- field of sensing and energy transfer on the micro- and nano-
lecular machines. A set of pillared paddlewheel MOFs were scales in fluid media.
prepared containing 9,10-bis(4-pyridylethynyl)triptycene with A 1,3,5-trisubstituted benzene was coupled with triptycene
the purpose to act simultaneously as a pillar and molecular ro- to incorporate rigid arms with two carboxylic acid moieties at
tator 268, three axially substituted dicarboxylate linkers of the end of the chain. A MOF 271 was then created by com-
varying lengths and steric bulk were also employed plexing the triptycene system with CuO.[331] This complex was
(Figure 50).[328] Changing the linker from benzene to a biphenyl studied computationally to investigate the effect triptycene
and then a triptycene moiety, 268 a, 268 b, and 268 c, showed has on methane adsorption properties. Calculations of meth-
2-fold, 4-fold, and no catenation, respectively, when crystalized ane adsorption properties were performed with Grand Canoni-
from DMF, in correlation to the amount of space available in cal Monte Carlo simulations and showed favorable results
their 2D frames. Tight packing is observed for the two catenat- when compared to known MOFs of a similar structure and top-
ed structures while the triptycene derivative shows no contacts ology. It was showed that the methane adsorption uptake was
between pillars and linkers in the lattice. Rotation is occurring significantly enhanced on a volumetric basis with this complex
in this compound via a Brownian three-fold jumping mecha- 271.
nism and, as there are no steric interactions in this molecule, it Terephthalic acid is one of the most commonly reported
is suggested that the confined DMF molecules in the lattice spacers in MOF constructions, although it has several draw-
cause the rotation. A hydrodynamic model was used to esti- backs, such as solid-state transparency only between 350 and
mate a four orders of magnitude greater viscosity of the DMF 800 nm. To extend transparency in the UV domain (below
MOF compared with that of the bulk liquid and this has been 320 nm) BCO 124 was employed as a terephthalic acid replace-
compared to the consistency of honey. The viscosity changes ment in a MOF construction 272 a along with ZnII as both are
allow an opportunity to analyze the dynamics of fluids under expected to have a higher transparency (Figure 51 i and ii).[327]
tight confinement at variable temperatures. A classic MOF-5,10 was prepared, with BCO 124 instead of
(Triptycenedicarboxylato)zinc MOFs 270 were prepared and terephthalic acid, and Zn4O clusters that arranged the moieties
constructed with paddle wheel secondary building units con- into a cubic network with BCO 124 on the edges and the zinc
taining different axial ligands.[329] 3D frameworks were made by cluster on the vertices. The BCO moiety was found to retain
a pillaring approach as triptycene paddlewheels 269 reliably the rigidity of the structure while removing aromaticity, thus
form layers with zinc nitrate. By employing different ligands, increasing transparency, making it highly suitable for the prep-
such as bis(4-pyridyl)-s-tetrazine 270 a and bis(4-pyridyl)-dime- aration of transparent metal–organic frameworks (TMOFs). The
thoxy-p-phenylenedivinylene 270 b, the functionalities of the TMOF was synthesized with high reproducibility, a good yield,
MOFs were modified. Guest-exchange behavior, microporosity, and was formed by self-assembly.
luminescence, and stability were investigated for these MOFs. The density functional based tight-binding method was
In was seen that the presence of 2D triptycene allowed for the used to compute the properties of an isoreticular series of
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4626 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Figure 51. Towards a “transparent MOF” showing, metal-view (i) and ligand-view (ii). DEF = N,N’-diethylformamide. View of molecular tunnel formation (iii).
Nax = axial nitrogen atoms; Neq = equatorial nitrogen atoms.
metal–organic frameworks (IRMOFs).[332] Again, Zn4O clusters 7. Application of Rigid-Linear Linkers in Small
are arranged in a cubic network composed this time of Molecule Drugs
cubane-1,4-dicarboxylic acid 36 or triptycene-9,10-dicarboxylic
acid 269 on the edges and the metal cluster on the vertices Over the years bioisosteres have been implemented in drug
forming 272 b and 272 c (Figure 51 i and ii). Results showed all design and development to overcome problems associated
MOFs to be energetically stable semiconductors or insulators with potential drug candidates. At the late stage of drug devel-
and that unsymmetric linkers caused marked distortions in the opment, the utilization of bioisosteres is often the only viable
zinc-oxo carboxylato rings while symmetric linkers show little option. Pharmacokinetic properties (PK) such as bioavailability,
or no influence on the geometry. solubility, metabolic stability, and toxicity limit a drugs’ applica-
Atomic charges with similar values are observed for the free tion even though good potency and selectivity may be ob-
building blocks and the solid MOFs, except those seen with served in vitro. Alternatively, bioisosteres have been employed
linking oxygen atoms as they change when going from the simply to expand the scope of a family of compounds but also
free linker to the MOF. This knowledge could allow for the cre- to investigate structure–activity relationships (SAR).
ation of materials for hydrogen storage and optical applica- Benzene bioisosteres have been investigated most exten-
tions amongst other applications. sively in the literature, but several examples of bioisosteres for
Layered double hydroxides (LDHs) are a class of claylike ethynyl, cyclohexane rings, adamantane, and tert-butyl and
anionic nanoscale minerals consisting of [Mg(OH)2]-like layers methyl groups have also been reported. Linear-aliphatic-rigid
in which trivalent ions have replaced ordinarily divalent cations linkers are ideal replacements for these functional groups as
to form positively charged sheets.[333] A cubane MOF was con- they can maintain the structure of the drug that is often crucial
structed when cubane-1,4-dicarboxylate (cubane-dc) anions to activity, offer metabolic stability when enzymatic action dra-
were incorporated into a Zn2Al LDH inorganic host. This was matically reduces the half-life of a drug, and increase the lipo-
achieved through means of the coprecipitation method, with philicity of a drug that may be required to cross the blood–
solutions of ZnII and AlIII nitrate salts and an alkaline solution of brain-barrier. Moreover, BCP has been shown to increase the
cubane-dc. DOS calculations computed with the DFT method aqueous solubility of a drug,[336] and, alongside cubane[337] and
and the molecular orbital models showed a redshift in the BCO, has been proven to increase the selectivity and potency
spectrum of the large intercalated cubane-dc anions with a for specific receptors.
subsequent lower band energy gap than that of Zn-Al-NO3-
LDH, which is a much smaller anion.[334]
The singly metal–metal-bonded complex [Rh2(cis-DAniF)2-
7.1. Aromatic bioisosteres
(CH3CNeq)4(CH3CNax)2](BF4)2 (DAniF = N,N’-di-p-anisylformamidi-
nate) was assembled with (Et4N + )2(Carb2@), in which Carb2@ is A popular option to overcome problems with the design and
the dicarboxylate anion of BCP and cubane 273 and 274, re- development of drug candidates is the use of bioisosteres.
spectively, amongst other groups to form square complexes Due to its ubiquity in most drug molecules benzene is often
(Figure 51 iii). In crystal form these complexes stack forming in- chosen as a target for bioisosteric
finite tunnels which can be closed to allow for the encapsula- manipulation.[338] Chosen for its ri-
tion of solvent molecules.[335] gidity, unique electronics and syn-
thetic accessibility, benzene is
known to be one of the leading
Figure 52. A visual concept of
causes for compound attrition in cubane as a benzene bioisos-
drug discovery (Figure 52).[339] tere.
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4627 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4628 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
adverse effects associated with LpPLA2, such as myocardial in- Utilized against a variety of leukemias,[358] commercially avail-
farction or ischemic stroke (Figure 55).[349] Darapladib has been able Gleevec, the mesylate salt of Imatinib 286 (Im-1)
shown to have good potency and lipophilicity while maintain- (Figure 57), is one of the first synthetic tyrosine kinase inhibi-
ing artificial membrane permeability. But, unfortunately, the in- tors (TKI). Im-1 has a high density of aromatic rings and high
hibitor has a suboptimal physicochemical profile, with a high
molecular weight, low aqueous solubility, and high property
forecast indices (PFI); a risk indicator of developability.[350] But
through the substitution of the suboptimal benzene ring with
a BCP moiety 283 a, the PK profile of the drug was improved
while maintaining potency.[351] This drug was synthesized over
a number of steps, the key transformation involved a dichloro-
carbene insertion into a bicyclo[1.1.0]butane system.
Great interest has been shown in resveratrol 284 due to its
wide range of therapeutic properties, such as antioxidant, anti-
cancer, antidiabetic, or cardioprotective (Figure 56).[352] Yet, its
application is hindered by its poor bioavailability.[353] Studies
Figure 57. The ABL1 kinase inhibitor Imatinib and its bicyclo[1.1.1]pentyl an-
alogue.
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4629 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4630 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4631 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
metabolism.[377] Compound 308 a proved to be a potent and 315 a and 316 a both showed subnanomolar potency at the 5-
selective inhibitor of the enzyme DGAT-1, with a superior PK HT1A receptor. The C@I bond was found to be stable both in
profiles and a further optimization of 307, resulted in the for- vivo and in vitro. Unfortunately, poor brain uptake of the
mation of BCO 309 with the replacement of bicyclic pyrazi- drugs was observed resulting in low concentrations in the
do[4,5-b][1,4]oxazine with a pyrazine moiety, to give an in- brain, especially in the hippocampus where large volumes of
creased potency at the hDGAT1 receptor amongst other desir- the target receptor are located, making these derivates unsuit-
able physiochemical properties. The cyclohexane and BCO de- able for SPECT. Fluorinated derivatives were also prepared for
rivatives were both synthesized, but the former proved most the cubyl and BCO analogues 315 b and 316 b, respectively.[383]
promising as a future drug candidate.[378] Good potency at the receptor was observed and this time with
The covalent Bruton’s Tyrosine Kinase (BTK) inhibitor Ibruti- high selectivity for the 5-HT1A R rich regions of the brain but
nib 310 is currently approved for mantle cell lymphoma and the major drawback seen with this analogue was the in vivo
chronic lymphocytic leukemia (Figure 64).[379] However, ana- enzymatic defluorination of the drug, deactivating the radio
ligand.
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4632 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
were proposed as cubanyl drugs which displayed moderate are needed to see if its potency was affected. Owing to a more
antitumor activity and anticancer activity, respectively. In these similar size, cubane makes a more suitable bioisostere for ben-
compounds cubane was shown to increases the lipophilicity of zene, thus ACUDA 323 c was prepared.[395] However, when
the compound allowing easier movement across cell mem- tested with the mGlu1 ligand 323 c only weak activity was ob-
branes and to possess minimal toxicity. Additionally, 322 was served and a nine-fold decrease in activity was observed com-
shown to have applications in aorta relaxation and calcium pared to BCP 323 b. This was attributed to the increase in
channel blocking. volume of the 3D cube, suggesting that cubane represents the
upper limit for the steric accessibility of the mGlu1 binding
7.4. Amino Acids site. Interestingly, while BCP 323 b has higher activity, ACUDA
323 c was shown to have remarkable selectivity, enabling it to
7.4.1. Glycine and alanine mGluR1 antagonists
be devoid of any effect at mGluR5, while under the same con-
Activated by synaptic release of l-glutamic acid 323, metabo- dition BCP 323 b acts as a partial mGluR5 agonist. A BCO
tropic glutamate (mGlu) receptors consist of eight (currently group was also incorporated into CPG framework 323 f, ex-
known) mGlu receptor subtypes that have been classified into panding the family of linear-rigid scaffolds employed. Unfortu-
three groups. Group I contains mGlu1 and mGlu5, which are nately though, testing in AV-12 cells showed that the non-nat-
positively coupled to phospholipase C (PLC) and mGlu1 has ural amino acid was inactive against human mGluR1 and
been linked to the cause and accentuation of post-ischemic mGluR5.
neuronal damage.[389] Thus, mGlu1 antagonists are potential To further ascertain the influence that the distance between
therapeutic agents in the treatment of CNS disorders such as the two pharmacophore groups plays and, additionally, to
ischemia, stroke, head trauma and Alzheimer’s disease.[390] Car- quantify the importance of the distal carboxylate group, the
boxyphenylglycines (CPGs) have been shown to be selective synthesis of BCP 323 h ((S)-TBPG) was carried out, characterized
mGlu1 antagonists over glutamate ionotropic receptors[391] and by the tetrazole moiety replacement of the carboxyl group.[396]
optimizations of this drug category resulted in benzene ana- This substitution compensated for the shorter distance of the
logues; S-4CPG 323 a, S-4C3HPG 323 d, and (+ +)M4CPG 323 g BCP-based moiety compared with that of the “standard” S-
which have all been shown to inhibit mGlu1 activity, albeit 4CPG. A 2.5-fold reduction in potency was observed at mGluR1
with drawbacks such as low potency and activation of the when compared with than the parent compound but it was
mGlu2 receptor subtypes (Figure 66).[392] While the coplanarity found to be devoid of affinity for the mGluR5 subtype. The re-
duction in activity was thought to be due to the reduced acidi-
ty of the tetrazole ring compared with the carboxylate and/or
due to the different hydrogen bonding geometry of the com-
pound. The tetrazole moiety was attached through the cyclo-
addition of tri-n-butyltin azide (nBu3SnN3) with a nitrile group.
Further studies were performed to investigate the influence
the introduction of lipophilic moieties in the 2’-position of the
core of (S)-CBPG 323 b would have on potency and selectivi-
ty.[397] Two chloro groups were introduced at the 2’-position of
the BCP of both stereoisomers and a racemate of a mono-
chloro BCP group was also synthesized, namely (R)-dichloroBCP
323 I, (S)-dichloroBCP 323 j, and chloroBCP 323 k. Functional
assays showed that all compounds had antagonist activity at
group I receptor subtypes but were unselective, working at
both mGlu1 and mGlu5 receptors. Docking studies showed
Figure 66. mGluR1 antagonists. that the antagonistic behavior observed was due to the pres-
ence of disfavored van der Waals interactions in the binding
site which arise because of a different orientation the drugs
between the a-amino acidic and the w-carboxy functionalities, take compared to the native (S)-glutamate.
introduced by the benzene moiety, is generally accepted to be To obtain a new class of acidic amino acids with specific ac-
a crucial feature of the CPG, whether it has other contributions tivities at excitatory amino acid (EAA) receptors, the w-carbox-
to activity was unknown. SAR studies carried out on the cur- ylate moiety of glutamic acid 323 (l-Glu) was substituted with
rent S-4CPG antagonist involved the substitution of the ben- a w-phosphonate group. The most potent example of a selec-
zene ring with different saturated, rigid hydrocarbons, such as tive mGluR3 agonist is l-AP4 324 a (Figure 67).[398] A first-choice
BCP, BCO, and cubane.[393, 394] strategy to achieve subtype selectivity often is conformational
BCP 323 b was shown to have good potency at the mGlu1 constraining and previous research with 4-PPG 324 b showed
receptor and little activity at the other subtypes in both in it to be a potent group III selective agonist. In search for new
vitro and in vivo tests, indicating that the benzene ring is not group III ligands to enable further characterization of this
of importance when linearity and rigidity are maintained. BCP family of receptors, a BCP bioisosteric replacement approach
is considerably shorter than an aromatic ring, so further tests was employed.[399a] Stereoselective Ugi condensations were
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4633 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4634 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
cubane-containing b-aminopropanoic acid 325 d and cubane- lipid interactions. At different hydrophobic positions of the
containing N-Bn-protected b-alanine 325 e was described. KIGAKI sequence, CF3-Bpg 326 was incorporated either as an l-
These b-amino acids are of interest as previous b-amino acids or a d-enantiomer. The 19F-labeled sequence showed that al-
have shown resistance to proteolysis[403] and form stable and though d-epimers are known for having higher aggregation
highly structured b-peptides.[404] A Mitsunobu C@C bond-form- thresholds than the l-epimers, aggregation was seen in both
ing reaction was employed to synthesize the b-amino acids (Figure 69).
and the addition of a lithium amide to an a,b-unsaturated
ketone.[401]
A number of different tyrosine 325 h and phenylalanine
325 g derivatives have also been reported in the litera-
ture.[124, 356] BCP analogues of these natural amino acids were
made to elucidate conformational and electronic effects in Figure 69. 3-(Trifluoromethyl)bicyclopent-[1.1.1]-1-yl glycine (CF3-Bpg).
peptides. The BCP-containing glycine derivative was synthe-
sized through the homologation of a carboxylic acid, followed
by a Strecker reaction, in eight steps.[124] The BCP-containing To investigate its use as a synthetic probe, the 19F-labeled
tyrosine analogue was accessed from the BCP aldehyde by a amino acid 3-(trifluoromethyl)BCPglycine 327 a (CF3-Bpg = 3-
Wittig reaction to form an a,b-unsaturated ester, this group (trifluoromethyl)bicyclopent-[1.1.1]-1-yl-glycine) was synthe-
was then transformed into a diazo derivative by using hydro- sized (Figure 70).[412] The presence of the nonconjugating BCP
hydrazination conditions.[356]
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4635 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
lems also occur in the case of alkyl 327 d, which has no rigidity
in its structure resulting in ambiguous analysis of the NMR
data obtained owing to its conformational flexibility. This limi- change (CODEX) experiment was used to validate the pro-
tation was overcome with aromatic 327 e as the position of posed label for 19F–19F distance measurements.[418] The intra-
the 19F atom is fixed, but when replacing aliphatic amino acids molecular 19F–19F distance was found to be approximately 8 a,
(Ala, Val, Ile, Leu) extensive racemization during peptide syn- which is much closer in value to the expected distance of 7.5–
thesis is observed. Thus, to overcome these problems, BCO 8.0 a in an ideal helix than the 6.6 a value obtained for
was utilized to synthesize the new aliphatic 19F-substituted BCO.[419] The slightly longer distance can be explained by the
amino acid (4-fluoroBCO)glycine 327 f.[416] Unfortunately, race- minor distortion seen of the a-helix in CD, but nevertheless F-
mization was still observed with the BCO derivative, although Bpg 327 g can still be effectively used as a label to measure in-
only partially, resulting in the two epimeric peptides 327 h/ terspin distances.
327 i upon synthesis with SPPS. The key transformation in the
synthesis of the amino acid 327 f was a decarboxylative fluori-
7.4.4. Non-natural peptides
nation of an aliphatic carboxylic acid with XeF2 in C6F6.
Following on from this research, an alternative to BCO 327 f To increase the metabolic stability and bioavailability of pep-
was sought to overcome the reduced reactivity of the amino tides, additional non-natural amino acids have been incorpo-
acid caused by its increased lipophilicity and steric bulk when rated into peptides. Adamantane-substituted peptides have
compared to natural aliphatic amino acids.[416] Hence, 3-fluoro- been shown to enhance the peptides ability to penetrate bio-
BCP-glycine (F-Bpg, 327 g) was prepared, a smaller, while still logical membranes, and they have been investigated for their
rigid and nonconjugated core, that allows for an increased ac- anti-tumor[420] and antimicrobial activities.[421] With structural
tivity of the bioisostere in SPPS (Figure 70). The interatomic similarities to adamantane, cubane-based derivatives are also a
distances in membrane-active peptides were determined by viable option for non-natural amino acids. The first cubane-
solid-state 19F NMR spectroscopy, made possible with F-Bpg based amino acid synthesized for its neuroprotective proper-
327 g as it avoids the problems associated with the previous ties was 4-carboxylcubylglycine 325 a.[394] As unfunctionalized
FAAs. Calculations showed that the smaller BCP unit was closer cubane is a closer mimic of hydrophobic amino acids such as
in likeness to the natural Leu/Ile than all other 19F labels in leucine, isoleucine, and phenylalanine, cubane derivative 325 i
terms of size and lipophilicity. was synthesized, as were the dipeptide derivatives 329 a–c
F-Bpg 327 g was incorporated into the antimicrobial peptide bearing cubane residues in place of side chains (Figure 72).[402]
PGLa 328 from the skin of Xenopus laevis, to evaluate the po- Due to the high sensitivity of the vinylcubane unit, initial at-
tential of the label in detecting the F···F contacts tempts to prepare a cubane-based alanine derivative via the
(Figure 71).[417] Manual SPPS was employed to synthesize the corresponding dehydroalanine were unsuccessful. However,
polypeptide and encouragingly no degradation, low reactivity, the successful synthesis of a cubane-based glycine derivative
or racemization of F-Bpg was observed.[402] The peptide was re- and cubane-substituted dipeptides 329 a–c in diastereomer-
constituted in 1,2-dimyristoyl-sn-glycero-3-phosphocholine ically pure form was achieved upon the addition of lithiated
(DMPC) bilayers and gave the expected two 19F resonances in cubane to a (R,S)-glyoxylate sulfinimine.
the 19F NMR spectrum. CD spectroscopy of the labeled peptide C@H activation was utilized to achieve an efficient synthesis
showed slight deviation from the wild-type peptide in its a- of N14-desacetoxytubulysin H (Tb1) and pretubulysin D, along-
helical character, probably caused by the destabilization of the side the derivatives tubulysin BCP 330 a and cubane 330 b.[422]
helix near the labeled sites. Overall CD showed the presence of The synthesized compounds were biologically evaluated with
a mostly a-helical-labeled peptide in the membrane mimicking an array of cancer cell lines. Notable results included the novel
environment and, albeit with reduced activity, the 19F peptide BCP analogue Tb14 330 a, which showed high potencies
remained antimicrobial. A center band only detection of ex- against certain cell lines such as uterine sarcoma and human
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4636 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4637 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
8. Perspective of Linkers
The systems we have presented all share the common theme
of being linear and disubstituted, ranging from bridgehead-to-
bridgehead distances of 1.85 a in BCP to 2.79 a in cubane
(Figure 76).
With regards to rigidity, being able to arrange functional
groups in a spatial defined manner, many other hydrocarbons Figure 78. The tetrahedral space.
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4638 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
9. Conclusions
Figure 80. Possible geometrical arrangements of different substituents (indi- In this Review article, the chemistry and applications of differ-
cated by different colors) for key framework molecules. ent, rigid, nonconjugated, linear hydrocarbons are highlighted.
It is hoped that this comprehensive study compiles the rele-
vant information about BCP, BCO, triptycene, and cubane into
A rather futuristic approach lies within utilizing rigid linker a “handbook” to provide chemists with the knowledge re-
systems in a dynamic fashion–order and turmoil in one mole- quired to select an appropriate hydrocarbon, depending on
cule. One might need molecules to be arranged in a certain their unique needs, whether it be for electron-transfer studies,
geometry, but would it not be even more covetable to use a MOF or liquid crystal constructions, molecular rotors or rods,
dynamic, covalent approach? Breaking and mending bonds, bioisosteres or drug motifs. What is more, the relevance of
but still in a defined conformational and, therefore, geomet- these systems has been long overlooked and disregarded be-
rical distinct fashion. This would create the possibility to use cause of their different chemistry when compared to the omni-
the rigid, but still flexible conformation of the linker molecules present benzene or acetylene motifs; thus, their chemistry has
to cope with the specialties of the environment. One could been highlighted once more. We hope this Review inspires
imagine a linker which can adjust the overall geometric ar- chemists to develop new and expanding methodologies to
rangement of the pharmacophores, to specifically fit into a access these molecules. The use of these unique scaffolds[446]
protein binding pocket? Current work utilizing this shape shift- will leave their shadow-existence once more robust cross-cou-
ing approach was presented by the Bode group.[439] They incor- pling methodologies (sp3-sp, sp3-sp2, sp3-sp3) have been devel-
porated a single 13C-label into the bullvalene backbone and oped. Nevertheless, the already prepared systems show highly
were able to differentiate dissimilar polyols by small changes interesting and unique properties in diverse areas, from bioi-
in the chemical shift and intensities (Figure 81).[440] With the re- sosteres to rigid rods. The rapid development within recent
cently developed method by the Fallon group, disubstituted years clearly shows the rising interest in these hydrocarbons
bullvalenes are easily available now and their computational with many more fascinating developments emerging.
network analysis is a useful tool to understand the energetic Naturally, there are more compounds that fulfill the require-
landscape of the various isomers.[441] ments of this Review article, such as the rigid-linear hydrocar-
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4639 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4640 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
c) M. J. Falkiner, S. W. Littler, K. J. McRae, G. P. Savage, J. Tsanaktsidis, [86] R. E. Dixon, A. Streitwieser, P. G. Williams, P. E. Eaton, J. Am. Chem. Soc.
Org. Process Res. Dev. 2013, 17, 1503 – 1509. 1991, 113, 357 – 358.
[58] a) A. de Meijere, S. Redlich, D. Frank, J. Magull, A. Hofmeister, H. [87] A. Streitwieser, Jr., W. R. Young, J. Am. Chem. Soc. 1969, 91, 529 – 530.
Menzel, B. Kçnig, J. Svoboda, Angew. Chem. Int. Ed. 2007, 46, 4658 – [88] T. W. Cole, C. J. Mayers, L. M. Stock, J. Am. Chem. Soc. 1974, 96, 4555 –
4660; Angew. Chem. 2007, 119, 4574 – 4576; b) J. C. Barborak, L. Watts, 4557.
R. Pettit, J. Am. Chem. Soc. 1966, 88, 1328 – 1329; c) L. F. Pelosi, W. T. [89] W. Adcock, Y. Baran, A. Filippi, M. Speranza, N. A. Trout, J. Org. Chem.
Miller, J. Am. Chem. Soc. 1976, 98, 4311 – 4312; d) R. Gleiter, M. Karcher, 2005, 70, 1029 – 1034.
Angew. Chem. Int. Ed. Engl. 1988, 27, 840 – 841; Angew. Chem. 1988, [90] a) W. Adcock, A. V. Blokhin, G. M. Elsey, N. H. Head, A. R. Krstic, M. D.
100, 851 – 852; e) R. Gleiter, S. Brand, Tetrahedron Lett. 1994, 35, 4969 – Levin, J. Michl, J. Munton, E. Pinkhassik, M. Robert, J.-M. Sav8ant, A.
4972. Shtarev, I. Stibo, J. Org. Chem. 1999, 64, 2618 – 2625; b) K. Bowden,
[59] P. E. Eaton, J. Tsanaktsidis, J. Am. Chem. Soc. 1990, 112, 876 – 878. D. C. Parkin, Can. J. Chem. 1969, 47, 177 – 183.
[60] K. Hassenruck, J. G. Radziszewski, V. Balaji, G. S. Murthy, A. J. McKinley, [91] K. B. Wiberg, J. Org. Chem. 2002, 67, 1613 – 1617.
D. E. David, V. M. Lynch, H. D. Martin, J. Michl, J. Am. Chem. Soc. 1990, [92] F. H. Allen, Acta Crystallogr. Sect. B 1984, 40, 64 – 72.
112, 873 – 874. [93] H. Irngartinger, S. Strack, F. Gredel, A. Dreuw, E. W. Della, Eur. J. Org.
[61] D. A. Hrovat, W. T. Borden, J. Am. Chem. Soc. 1990, 112, 875 – 876. Chem. 1999, 1253 – 1264.
[62] P. E. Eaton, Angew. Chem. Int. Ed. Engl. 1992, 31, 1421 – 1436; Angew. [94] T. Koopmans, Physica 1934, 1, 104 – 113.
Chem. 1992, 104, 1447 – 1462. [95] P. Bischof, P. E. Eaton, R. Gleiter, E. Heilbronner, T. B. Jones, H. Musso, A.
[63] L. Hedberg, K. Hedberg, P. E. Eaton, N. Nodari, A. G. Robiette, J. Am. Schmelzer, R. Stober, Helv. Chim. Acta 1978, 61, 547 – 557.
Chem. Soc. 1991, 113, 1514 – 1517. [96] E. Honegger, E. Heilbronner, T. Urbanek, H.-D. Martin, Helv. Chim. Acta
[64] E. B. Fleischer, J. Am. Chem. Soc. 1964, 86, 3889 – 3890. 1985, 68, 23 – 38.
[65] A. Almenningen, T. Jonvik, H. D. Martin, T. Urbanek, J. Mol. Struct. [97] E. Honegger, E. Heilbronner, N. Heß, H.-D. Martin, Chem. Ber. 1987,
1985, 128, 239 – 247. 120, 187 – 193.
[66] Z. Li, S. L. Anderson, J. Phys. Chem. A 2003, 107, 1162 – 1174. [98] R. Gleiter, K.-H. Pfeifer, G. Szeimies, U. Bunz, Angew. Chem. Int. Ed. Engl.
[67] B. D. Kybett, S. Carroll, P. Natalis, D. W. Bonnell, J. L. Margrave, J. L. 1990, 29, 413 – 415; Angew. Chem. 1990, 102, 418 – 420.
Franklin, J. Am. Chem. Soc. 1966, 88, 626 – 626. [99] M. Ehara, S. Fukawa, H. Nakatsuji, D. E. David, E. Z. Pinkhassik, M. D.
[68] M. V. Roux, G. Mart&n-Valcarcel, R. Notario, S. Kini, J. S. Chickos, J. F. Levin, M. Apostol, J. Michl, Chem. Asian J. 2007, 2, 1007 – 1019.
Liebman, J. Chem. Eng. Data 2011, 56, 1220 – 1228. [100] M. Braga, Chem. Phys. 1996, 213, 159 – 164.
[101] O. Schafer, M. Allan, G. Szeimies, M. Sanktjohanser, Chem. Phys. Lett.
[69] a) G. W. Griffin, A. P. Marchand, Chem. Rev. 1989, 89, 997 – 1010; b) F.
1992, 195, 293 – 297.
Agapito, R. C. Santos, R. M. Borges dos Santos, J. A. Martinho Simles, J.
[102] a) J. R. Winkler, H. B. Gray, J. Am. Chem. Soc. 2014, 136, 2930 – 2939;
Phys. Chem. A 2015, 119, 2998 – 3007.
b) C. Liang, M. D. Newton, J. Phys. Chem. 1993, 97, 3199 – 3211; c) M. N.
[70] a) H. Hopf, in Classics in Hydrocarbon Chemistry: Syntheses, Concepts,
Paddon-Row, K. D. Jordan, J. Am. Chem. Soc. 1993, 115, 2952 – 2960.
Perspectives, Wiley-VCH, Weinheim, 2000, p. 547; b) H. Hopf, J. F. Lieb-
[103] A. Baeyer, Ber. Dtsch. Chem. Ges. 1885, 18, 2269 – 2281.
man, H. M. Perks, in The Chemistry of Functional Groups (Eds.: Z. Rap-
[104] a) K. S. Pitzer, J. Chem. Phys. 1937, 5, 473; b) J. D. Kemp, K. S. Pitzer, J.
poport, J. F. Liebman), Wiley, Chichester, 2005, pp. 1061 – 1109; c) A.
Chem. Phys. 1936, 4, 749 – 750.
Bashir-Hashemi, H. Higuchi, in The Chemistry of Functional Groups
[105] J. D. Dunitz, V. Prelog, Angew. Chem. 1960, 72, 896 – 902.
(Eds.: Z. Rappoport, J. F. Liebman), Wiley, Chichester, 2005, pp. 873 –
[106] J. W. Knowlton, F. D. Rossini, J. Res. Natl. Bur. Stand. 1949, 43, 113 – 115.
921.
[107] S. W. Slayden, J. F. Liebman, Chem. Rev. 2001, 101, 1541 – 1566.
[71] S. Toyota, Chem. Rev. 2010, 110, 5398 – 5424.
[108] E. J. Prosen, W. H. Johnson, F. D. Rossini, J. Res. Natl. Bur. Stand. 1946,
[72] W. F. Sanjuan-Szklarz, A. A. Hoser, M. Gutmann, A. Ø. Madsen, K. Woź-
37, 51 – 56.
niak, IUCrJ 2016, 3, 61 – 70.
[109] K. B. Wiberg, G. Bonneville, R. Dempsey, Isr. J. Chem. 1983, 23, 85 – 92.
[73] T. Yildirim, P. M. Gehring, D. A. Neumann, P. E. Eaton, T. Emrick, Carbon
[110] W.-K. Wong, E. F. Westrum, J. Phys. Chem. 1970, 74, 1303 – 1308.
1998, 36, 809 – 815.
[111] D. L. Rodgers, E. F. Westrum, J. T. S. Andrews, J. Chem. Thermodyn.
[74] B. A. Chalmers, H. Xing, S. Houston, C. Clark, S. Ghassabian, A. Kuo, B.
1973, 5, 733 – 739.
Cao, A. Reitsma, C.-E. P. Murray, J. E. Stok, G. M. Boyle, C. J. Pierce, S. W. [112] J. F. Liebman, A. Greenberg, Chem. Rev. 1976, 76, 311 – 365.
Littler, D. A. Winkler, P. V. Bernhardt, C. Pasay, J. J. De Voss, J. McCarthy, [113] I. Alkorta, N. Campillo, I. Rozas, J. Elguero, J. Org. Chem. 1998, 63,
P. G. Parsons, G. H. Walter, M. T. Smith, H. M. Cooper, S. K. Nilsson, J. 7759 – 7763.
Tsanaktsidis, G. P. Savage, C. M. Williams, Angew. Chem. Int. Ed. 2016, [114] J. I.-C. Wu, P. v. R. Schleyer, Pure Appl. Chem. 2013, 85, 921 – 940.
55, 3580 – 3585; Angew. Chem. 2016, 128, 3644 – 3649. [115] D. A. Hrovat, W. T. Borden, J. Am. Chem. Soc. 1990, 112, 3227 – 3228.
[75] G. S. Murthy, K. Hassenruck, V. M. Lynch, J. Michl, J. Am. Chem. Soc. [116] J. M. Lehn, G. Wipff, Chem. Phys. Lett. 1972, 15, 450 – 454.
1989, 111, 7262 – 7263. [117] a) K. B. Wiberg, Z. van Williams, J. Am. Chem. Soc. 1967, 89, 3373 –
[76] J. D. Rehm, B. Ziemer, G. Szeimies, Eur. J. Org. Chem. 1999, 2079 – 2085. 3374; b) K. B. Wiberg, N. McMurdie, J. Am. Chem. Soc. 1994, 116,
[77] J. L. Adcock, A. A. Gakh, J. L. Pollitte, C. Woods, J. Am. Chem. Soc. 1992, 11990 – 11998.
114, 3980 – 3981. [118] a) S. V#zquez, P. Camps, Tetrahedron 2005, 61, 5147 – 5208; b) D. A.
[78] P. R. Schreiner, L. V. Chernish, P. A. Gunchenko, E. Y. Tikhonchuk, H. Hrovat, W. T. Borden, J. Am. Chem. Soc. 1988, 110, 4710 – 4718.
Hausmann, M. Serafin, S. Schlecht, J. E. P. Dahl, R. M. K. Carlson, A. A. [119] P. E. Eaton, J. P. Zhou, J. Am. Chem. Soc. 1992, 114, 3118 – 3120.
Fokin, Nature 2011, 477, 308 – 311. [120] R. M. Moriarty, S. M. Tuladhar, R. Penmasta, A. K. Awasthi, J. Am. Chem.
[79] N. Muller, D. E. Pritchard, J. Chem. Phys. 1959, 31, 768 – 780. Soc. 1990, 112, 3228 – 3230.
[80] H. E. Gottlieb, V. Kotlyar, A. Nudelman, J. Org. Chem. 1997, 62, 7512 – [121] W. T. Borden, Chem. Rev. 1989, 89, 1095 – 1109.
7515. [122] P. E. Eaton, C. X. Yang, Y. Xiong, J. Am. Chem. Soc. 1990, 112, 3225 –
[81] a) A. Yoshimura, J. M. Fuchs, K. R. Middleton, A. V. Maskaev, G. T. Rohde, 3226.
A. Saito, P. S. Postnikov, M. S. Yusubov, V. N. Nemykin, V. V. Zhdankin, [123] R. J. Doedens, P. E. Eaton, E. B. Fleischer, Eur. J. Org. Chem. 2017, 2627 –
Chem. Eur. J. 2017, 23, 16738 – 16742; b) R. Mello, M. Fiorentino, C. 2630.
Fusco, R. Curci, J. Am. Chem. Soc. 1989, 111, 6749 – 6757. [124] Y. P. Auberson, C. Brocklehurst, M. Furegati, T. C. Fessard, G. Koch, A.
[82] E. W. Della, P. T. Hine, H. K. Patney, J. Org. Chem. 1977, 42, 2940 – 2941. Decker, L. La Vecchia, E. Briard, ChemMedChem 2017, 12, 590 – 598.
[83] E. W. Della, E. Cotsaris, P. T. Hine, P. E. Pigou, Aust. J. Chem. 1981, 34, [125] D. N. Kevill, M. J. D’Souza, R. M. Moriarty, S. M. Tuladhar, R. Penmasta,
913 – 916. A. K. Awasthi, J. Chem. Soc. Chem. Commun. 1990, 623 – 624.
[84] C. J. Rhodes, J. C. Walton, E. W. Della, J. Chem. Soc. Perkin Trans. 2 [126] S. Jalife, S. Mondal, J. L. Cabellos, G. Martinez-Guajardo, M. A. Fernan-
1993, 2125 – 2128. dez-Herrera, G. Merino, Chem. Commun. 2016, 52, 3403 – 3405.
[85] a) Z. B. Maksić, M. Eckert-Maksić, Tetrahedron 1969, 25, 5113 – 5114; [127] C. W. Jefford, R. M. McCreadie, P. Muller, B. Siegfried, J. Chem. Educ.
b) T.-Y. Luh, L. M. Stock, J. Am. Chem. Soc. 1974, 96, 3712 – 3713. 1971, 48, 708 – 710.
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4641 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
[128] J. W. Wilt, T. P. Malloy, J. Org. Chem. 1972, 37, 2781 – 2782. [166] R. Stober, H. Musso, Angew. Chem. Int. Ed. Engl. 1977, 16, 415 – 416;
[129] T. W. Cole, PhD Thesis, University of Chicago, Chicago, IL, 1966. Angew. Chem. 1977, 89, 430 – 431.
[130] B. J. Smith, J. Tsanaktsidis, J. Org. Chem. 1997, 62, 5709 – 5712. [167] R. Stober, H. Musso, E. Ōsawa, Tetrahedron 1986, 42, 1757 – 1761.
[131] Z. Tian, S. R. Kass, Chem. Rev. 2013, 113, 6986 – 7010. [168] A. J. H. Klunder, B. Zwanenburg, Tetrahedron 1975, 31, 1419 – 1426.
[132] C. H. DePuy, S. Gronert, S. E. Barlow, V. M. Bierbaum, R. Damrauer, J. [169] V. M. Carroll, D. N. Harpp, R. Priefer, Tetrahedron Lett. 2008, 49, 2677 –
Am. Chem. Soc. 1989, 111, 1968 – 1973. 2680.
[133] a) C. H. DePuy, V. M. Bierbaum, L. A. Flippin, J. J. Grabowski, G. K. King, [170] A. Fasolini, Master Thesis, University of Bologna, Bologna, 2016.
R. J. Schmitt, J. Am. Chem. Soc. 1979, 101, 6443 – 6445; b) C. H. DePuy, [171] A.-D. Schleter, Macromolecules 1988, 21, 1208 – 1211; A.-D. Schleter,
V. M. Bierbaum, L. A. Flippin, J. J. Grabowski, G. K. King, R. J. Schmitt, Angew. Chem. Int. Ed. Engl. 1988, 27, 296 – 298; Angew. Chem. 1988,
S. A. Sullivan, J. Am. Chem. Soc. 1980, 102, 5012 – 5015. 100, 283 – 285.
[134] E. E. Ferguson, F. C. Fehsenfeld, A. L. Schmeltekopf, in Advances in [172] R. M. B-r, S. Kirschner, M. Nieger, S. Br-se, Chem. Eur. J. 2018, 24,
Atomic, Molecular, and Optical Physics (Ed.: D. R. Bates), Academic 1373 – 1382.
Press, Boston, 1965, pp. 1 – 56. [173] P. Kaszynski, J. Michl, The Chemistry of the Cyclopropyl Group: Supple-
[135] J. L. Beauchamp, L. R. Anders, J. D. Baldeschwieler, J. Am. Chem. Soc. ment, Wiley, Chichester, 1995.
1967, 89, 4569 – 4577. [174] J. Waser, E. M. Carreira, Angew. Chem. Int. Ed. 2004, 43, 4099 – 4102;
[136] C. H. DePuy, V. M. Bierbaum, R. Damrauer, J. Am. Chem. Soc. 1984, 106, Angew. Chem. 2004, 116, 4191 – 4194.
4051 – 4053. [175] K. D. Bunker, N. W. Sach, Q. Huang, P. F. Richardson, Org. Lett. 2011, 13,
[137] A. Fattahi, L. Lis, Z. A. Tehrani, S. S. Marimanikkuppam, S. R. Kass, J. 4746 – 4748.
Org. Chem. 2012, 77, 1909 – 1914. [176] J. Kanazawa, K. Maeda, M. Uchiyama, J. Am. Chem. Soc. 2017, 139,
[138] X.-S. Xue, P. Ji, B. Zhou, J.-P. Cheng, Chem. Rev. 2017, 117, 8622 – 8648. 17791 – 17794.
[139] A. Fattahi, R. E. McCarthy, M. R. Ahmad, S. R. Kass, J. Am. Chem. Soc. [177] R. Gianatassio, J. M. Lopchuk, J. Wang, C.-M. Pan, L. R. Malins, L. Prieto,
2003, 125, 11746 – 11750. T. A. Brandt, M. R. Collins, G. M. Gallego, N. W. Sach, J. E. Spangler, H.
[140] a) R. A. Seburg, R. R. Squires, Int. J. Mass. Spectrom. 1997, 167 – 168, Zhu, J. Zhu, P. S. Baran, Science 2016, 351, 241 – 246.
541 – 557; b) D. R. Reed, S. R. Kass, K. R. Mondanaro, W. P. Dailey, J. Am. [178] M. Messner, S. I. Kozhushkov, A. de Meijere, Eur. J. Org. Chem. 2000,
Chem. Soc. 2002, 124, 2790 – 2795; c) M. Hare, T. Emrick, P. E. Eaton, 1137 – 1155.
S. R. Kass, J. Am. Chem. Soc. 1997, 119, 237 – 238; d) R. R. Sauers, Tetra- [179] I. S. Makarov, C. E. Brocklehurst, K. Karaghiosoff, G. Koch, P. Knochel,
hedron 1999, 55, 10013 – 10026. Angew. Chem. Int. Ed. 2017, 56, 12774 – 12777; Angew. Chem. 2017,
[141] J. M. Lehn, G. Wipff, Tetrahedron Lett. 1980, 21, 159 – 162. 129, 12949 – 12953.
[142] J. Bredt, Justus Liebigs Ann. der Chem. 1924, 437, 1 – 13. [180] D. F. J. Caputo, C. Arroniz, A. B. Derr, J. J. Mousseau, A. F. Stepan, S. J.
[143] J. C. Walton, Chem. Soc. Rev. 1992, 21, 105 – 112. Mansfield, E. A. Anderson, Chem. Sci. 2018, 9, 5295 – 5300.
[144] E. W. Della, G. M. Elsey, N. J. Head, J. C. Walton, J. Chem. Soc. Chem. [181] R. J. Ranson, R. M. G. Roberts, J. Organomet. Chem. 1976, 107, 295 –
Commun. 1990, 1589 – 1591. 300.
[145] R. R. Sauers, Comput. Theor. Chem. 2011, 970, 73 – 78. [182] V. I. Dodero, M. B. Faraoni, D. C. Gerbino, L. C. Koll, A. E. ZfflÇiga, T. N.
[146] B. Maillard, J. C. Walton, J. Chem. Soc. Chem. Commun. 1983, 16, 900 – Mitchell, J. C. Podest#, Organometallics 2005, 24, 1992 – 1995.
901. [183] Y. Kawada, H. Iwamura, J. Org. Chem. 1981, 46, 3357 – 3359.
[147] M. Ohsaku, A. Imamura, K. Hirao, T. Kawamura, Tetrahedron 1979, 35, [184] Z. Zielinski, N. Presseau, R. Amorati, L. Valgimigli, D. A. Pratt, J. Am.
701 – 706. Chem. Soc. 2014, 136, 1570 – 1578.
[148] J. W. Verhoeven, Recl. Trav. Chim. Pays-Bas 1980, 99, 369 – 379. [185] T. Nakamoto, S. Hayashi, W. Nakanishi, J. Org. Chem. 2008, 73, 9259 –
[149] G. T. Binmore, J. C. Walton, W. Adcock, C. I. Clark, A. R. Kristic, Magn. 9263.
Reson. Chem. 1995, 33, S53 – S59. [186] R. J. Baker, M. Brym, C. Jones, M. Waugh, J. Organomet. Chem. 2004,
[150] P. J. Krusic, T. A. Rettig, P. v. R. Schleyer, J. Am. Chem. Soc. 1972, 94, 689, 781 – 790.
995 – 997. [187] P. D. Bartlett, F. D. Greene, J. Am. Chem. Soc. 1954, 76, 1088 – 1096.
[151] J. C. Walton, J. Chem. Soc. Perkin Trans. 2 1987, 2, 231 – 235. [188] K. Okada, K. Okamoto, M. Oda, J. Chem. Soc. Chem. Commun. 1989,
[152] a) P. R. Schreiner, A. Wittkopp, P. A. Gunchenko, A. I. Yaroshinsky, S. A. 1636 – 1637.
Peleshanko, A. A. Fokin, Chem. Eur. J. 2001, 7, 2739 – 2744; b) X. Z. Qin, [189] M. J. S. Dewar, R. S. Goldberg, J. Am. Chem. Soc. 1970, 92, 1582 – 1586.
A. D. Trifunac, P. E. Eaton, Y. Xiong, J. Am. Chem. Soc. 1990, 112, 4565 – [190] K. B. Wiberg, W. E. Pratt, W. F. Bailey, J. Am. Chem. Soc. 1977, 99, 2297 –
4567; c) A. Marcinek, J. Rogowski, J. G8bicki, G.-F. Chen, F. Williams, J. 2302.
Phys. Chem. A 2000, 104, 5265 – 5268. [191] K. Higashiguchi, K. Yumoto, K. Matsuda, Org. Lett. 2010, 12, 5284 –
[153] H.-D. Martin, T. Urbanek, P. Pfçhler, R. Walsh, J. Chem. Soc. Chem. 5286.
Commun. 1985, 964 – 965. [192] W. Adcock, G. B. Kok, J. Org. Chem. 1985, 50, 1079 – 1087.
[154] P. E. Eaton, L. Cassar, J. Halpern, J. Am. Chem. Soc. 1970, 92, 6366 – [193] X. Qian, A. Auffrant, A. Felouat, C. Gosmini, Angew. Chem. Int. Ed. 2011,
6368. 50, 10402 – 10405; Angew. Chem. 2011, 123, 10586 – 10589.
[155] a) S. Moss, B. T. King, A. de Meijere, S. I. Kozhushkov, P. E. Eaton, J. [194] W. Adam, F. Mazenod, Y. Nishizawa, P. S. Engel, S. A. Baughman, W.-K.
Michl, Org. Lett. 2001, 3, 2375 – 2377; b) G. Durkj, I. Jalsovszky, Tetrahe- Chae, D. W. Horsey, H. Quast, B. Seiferling, J. Am. Chem. Soc. 1983, 105,
dron 2013, 69, 5160 – 5163. 6141 – 6145.
[156] L. Cassar, P. E. Eaton, J. Halpern, J. Am. Chem. Soc. 1970, 92, 3515 – [195] R. H. Pouwer, J. B. Harper, K. Vyakaranam, J. Michl, C. M. Williams, C. H.
3518. Jessen, P. V. Bernhardt, Eur. J. Org. Chem. 2007, 241 – 248.
[157] K. B. Wiberg, S. T. Waddell, J. Am. Chem. Soc. 1990, 112, 2194 – 2216. [196] F. Toriyama, J. Cornella, L. Wimmer, T.-G. Chen, D. D. Dixon, G. Creech,
[158] D. H. R. Barton, D. Crich, W. B. Motherwell, J. Chem. Soc. Chem. P. S. Baran, J. Am. Chem. Soc. 2016, 138, 11132 – 11135.
Commun. 1983, 939 – 942. [197] C. Li, J. Wang, L. M. Barton, S. Yu, M. Tian, D. S. Peters, M. Kumar, A. W.
[159] P. E. Eaton, Y. C. Yip, J. Am. Chem. Soc. 1991, 113, 7692 – 7697. Yu, K. A. Johnson, A. K. Chatterjee, M. Yan, P. S. Baran, Science 2017,
[160] S. Y. Choi, P. E. Eaton, M. Newcomb, Y. C. Yip, J. Am. Chem. Soc. 1992, 356, eaam7355.
114, 6326 – 6329. [198] A. Fawcett, J. Pradeilles, Y. Wang, T. Mutsuga, E. L. Myers, V. K. Aggar-
[161] B. P. Branchaud, A. G. Glenn, H. C. Stiasny, J. Org. Chem. 1991, 56, wal, Science 2017, 357, 283 – 286.
6656 – 6659. [199] J. M. Smith, T. Qin, R. R. Merchant, J. T. Edwards, L. R. Malins, Z. Liu, G.
[162] P. E. Eaton, K. L. Hoffmann, J. Am. Chem. Soc. 1987, 109, 5285 – 5286. Che, Z. Shen, S. A. Shaw, M. D. Eastgate, P. S. Baran, Angew. Chem. Int.
[163] N. Chen, M. Jones, J. Phys. Org. Chem. 1988, 1, 305 – 308. Ed. 2017, 56, 11906 – 11910; Angew. Chem. 2017, 129, 12068 – 12072.
[164] P. E. Eaton, R. B. Appell, J. Am. Chem. Soc. 1990, 112, 4055 – 4057. [200] J. T. Edwards, R. R. Merchant, K. S. McClymont, K. W. Knouse, T. Qin,
[165] N. Chen, M. Jones, W. R. White, M. S. Platz, J. Am. Chem. Soc. 1991, 113, L. R. Malins, B. Vokits, S. A. Shaw, D.-H. Bao, F.-L. Wei, T. Zhou, M. D.
4981 – 4992. Eastgate, P. S. Baran, Nature 2017, 545, 213 – 218.
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4642 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
[201] R. R. Merchant, J. T. Edwards, T. Qin, M. M. Kruszyk, C. Bi, G. Che, D.-H. [230] a) L. Hammarstrçm, F. Barigelletti, L. Flamigni, N. Armaroli, A. Sour, J.-P.
Bao, W. Qiao, L. Sun, M. R. Collins, O. O. Fadeyi, G. M. Gallego, J. J. Collin, J.-P. Sauvage, J. Am. Chem. Soc. 1996, 118, 11972 – 11973; b) F.
Mousseau, P. Nuhant, P. S. Baran, Science 2018, 360, 75 – 80. Barigelletti, L. Flamigni, J.-P. Collin, J.-P. Sauvage, Chem. Commun.
[202] D. W. C. MacMillan, Y. Liang, X. Zhang, Decarboxylative sp3 C@N Cou- 1997, 333 – 410.
pling via Dual Copper/Photoredox Catalysis, ChemRxiv, 2018. [231] Q. Wei, E. Galoppini, Tetrahedron 2004, 60, 8497 – 8508.
[203] T. Patra, D. Maiti, Chem. Eur. J. 2017, 23, 7382 – 7401. [232] G. Vives, A. Gonzalez, J. Jaud, J.-P. Launay, G. Rapenne, Chem. Eur. J.
[204] R. M. Moriarty, J. S. Khosrowshahi, T. M. Dalecki, J. Chem. Soc. Chem. 2007, 13, 5622 – 5631.
Commun. 1987, 675 – 676. [233] P. F. H. Schwab, M. D. Levin, J. Michl, Chem. Rev. 1999, 99, 1863 – 1934.
[205] G. A. Olah, C. S. Lee, G. K. S. Prakash, R. M. Moriarty, M. S. C. Rao, J. Am. [234] A. Carella, G. Rapenne, J.-P. Launay, New J. Chem. 2005, 29, 288 – 290.
Chem. Soc. 1993, 115, 10728 – 10732. [235] A. Juris, V. Balzani, F. Barigelletti, S. Campagna, P. Belser, A. von Zelew-
[206] J. Wlochal, R. D. M. Davies, J. Burton, Org. Lett. 2014, 16, 4094 – 4097. sky, Coord. Chem. Rev. 1988, 84, 85 – 277.
[207] S. Plunkett, K. J. Flanagan, B. Twamley, M. O. Senge, Organometallics [236] A. Beyeler, P. Belser, Coord. Chem. Rev. 2002, 230, 29 – 39.
2015, 34, 1408 – 1414. [237] a) M. O. Senge, Chem. Commun. 2006, 243 – 256; b) M. O. Senge, Chem.
[208] S. Bernhard, G. Locke, S. Plunkett, A. Meindl, K. Flanagan, M. O. Senge, Commun. 2011, 47, 1943 – 1960; c) M. O. Senge, S. A. MacGowan, J. M.
Chem. Eur. J. 2018, 24, 1026 – 1030. O’Brien, Chem. Commun. 2015, 51, 17031 – 17063.
[209] T. Qin, L. R. Malins, J. T. Edwards, R. R. Merchant, A. J. E. Novak, J. Z. [238] a) J. R. Bolton, T.-F. Ho, S. Liauw, A. Siemiarczuk, C. S. K. Wan, A. C.
Zhong, R. B. Mills, M. Yan, C. Yuan, M. D. Eastgate, P. S. Baran, Angew. Weedon, J. Chem. Soc. Chem. Commun. 1985, 559 – 560; b) D. N. Bera-
Chem. Int. Ed. 2017, 56, 260 – 265; Angew. Chem. 2017, 129, 266 – 271. tan, J. Am. Chem. Soc. 1986, 108, 4321 – 4326; c) A. D. Joran, B. A.
[210] R. Gianatassio, S. Kawamura, C. L. Eprile, K. Foo, J. Ge, A. C. Burns, M. R. Leland, G. G. Geller, J. J. Hopfield, P. B. Dervan, J. Am. Chem. Soc. 1984,
Collins, P. S. Baran, Angew. Chem. Int. Ed. 2014, 53, 9851 – 9855; Angew. 106, 6090 – 6092.
Chem. 2014, 126, 10009 – 10013. [239] a) L. M. Urner, M. Sekita, N. Trapp, W. B. Schweizer, M. Wçrle, J.-P. Gis-
[211] a) G. M. Locke, M. O. Senge, ECS Trans. 2016, 72, 1 – 11; b) A. A. Ryan, selbrecht, C. Boudon, D. M. Guldi, F. Diederich, Eur. J. Org. Chem. 2015,
M. O. Senge, Photochem. Photobiol. Sci. 2015, 14, 638 – 660. 91 – 108; b) T. A. Reekie, M. Sekita, L. M. Urner, S. Bauroth, L. Ruhlmann,
[212] a) G. McDermott, S. M. Prince, A. A. Freer, A. M. Hawthornthwaite-Law- J.-P. Gisselbrecht, C. Boudon, N. Trapp, T. Clark, D. M. Guldi, F. Dieder-
less, M. Z. Papiz, R. J. Cogdell, N. W. Isaacs, Nature 1995, 374, 517 – 521; ich, Chem. Eur. J. 2017, 23, 6357 – 6369.
b) M. O. Senge, A. A. Ryan, K. A. Letchford, S. A. MacGowan, T. Mielke, [240] a) A. Osuka, R.-P. Zhang, K. Maruyama, N. Mataga, Y. Tanaka, T. Okada,
Symmetry 2014, 6, 781 – 843; c) M. R. Wasielewski, Chem. Rev. 1992, 92, Chem. Phys. Lett. 1993, 215, 179 – 184; b) A. Osuka, R.-P. Zhang, K. Mar-
uyama, T. Ohno, K. Nozaki, Bull. Chem. Soc. Jpn. 1993, 66, 3773 – 3782.
435 – 461; d) H. Kurreck, M. Huber, Angew. Chem. Int. Ed. Engl. 1995, 34,
[241] C. F. Portela, J. Brunckova, J. L. Richards, B. Schçllhorn, Y. Iamamoto, D.
849 – 866; Angew. Chem. 1995, 107, 929 – 947; e) D. Gust, T. A. Moore,
Magde, T. G. Traylor, C. L. Perrin, J. Phys. Chem. A 1999, 103, 10540 –
A. L. Moore, Acc. Chem. Res. 1995, 28, 40 – 48; f) Q. F. Yan, Z. Y. Luo, K.
10552.
Cai, Y. G. Ma, D. H. Zhao, Chem. Soc. Rev. 2014, 43, 4199 – 4221.
[242] J. Andr8asson, G. Kodis, T. Ljungdahl, A. L. Moore, T. A. Moore, D. Gust,
[213] H. E. Zimmerman, T. D. Goldman, T. K. Hirzel, S. P. Schmidt, J. Org.
J. M,rtensson, B. Albinsson, J. Phys. Chem. A 2003, 107, 8825 – 8833.
Chem. 1980, 45, 3933 – 3951.
[243] K. Pettersson, K. Kils,, J. M,rtensson, B. Albinsson, J. Am. Chem. Soc.
[214] H. E. Zimmerman, Y. A. Lapin, E. E. Nesterov, G. A. Sereda, J. Org. Chem.
2004, 126, 6710 – 6719.
2000, 65, 7740 – 7746.
[244] K. Pettersson, A. Kyrychenko, E. Rçnnow, T. Ljungdahl, J. M,rtensson,
[215] H. Hokari, U. Akiba, M. Fujihira, J. Chem. Soc. Chem. Commun. 1995,
B. Albinsson, J. Phys. Chem. A 2006, 110, 310 – 318.
180, 2139 – 2140.
[245] a) H. Lodish, S. L. Zipursky, P. Matsudaira, D. Baltimore, J. Darnell, Mo-
[216] H. Langhals, A. J. Esterbauer, A. Walter, E. Riedle, I. Pugliesi, J. Am.
lecular Cell Biology, W. H. Freeman and Company, New York, 2000;
Chem. Soc. 2010, 132, 16777 – 16782.
b) D. Bray, Cell Movements: From Molecules to Mobility, Garland, New
[217] A. de Meijere, L. Zhao, V. N. Belov, M. Bossi, M. Noltemeyer, S. W. Hell,
York, 2001; c) J. Howard, Mechanics of Motor Proteins and the Cytoske-
Chem. Eur. J. 2007, 13, 2503 – 2516.
leton, Sinauer Associates, Sunderland, 2001; d) M. Schliwa, G. Woehlke,
[218] A. Karimata, H. Kawauchi, S. Suzuki, M. Kozaki, N. Ikeda, K. Keyaki, K.
Nature 2003, 422, 759 – 765; e) A. B. Kolomeisky, M. E. Fisher, Annu. Rev.
Nozaki, K. Akiyama, K. Okada, Chem. Lett. 2013, 42, 794 – 830.
Phys. Chem. 2007, 58, 675 – 695; f) V. Balzani, M. Gjmez-Ljpez, J. F.
[219] D. E. Stasiw, J. Zhang, G. Wang, R. Dangi, B. W. Stein, D. A. Shultz, M. L. Stoddart, Acc. Chem. Res. 1998, 31, 405 – 414; g) K. Kinbara, T. Aida,
Kirk, L. Wojtas, R. D. Sommer, J. Am. Chem. Soc. 2015, 137, 9222 – 9225. Chem. Rev. 2005, 105, 1377 – 1400.
[220] R. H. Goldsmith, J. Vura-Weis, A. M. Scott, S. Borkar, A. Sen, M. A. [246] A. G. Douglass, B. Both, P. Kaszynski, J. Mater. Chem. 1999, 9, 683 – 686.
Ratner, M. R. Wasielewski, J. Am. Chem. Soc. 2008, 130, 7659 – 7669. [247] H. M. Abdullah, G. W. Gray, K. J. Toyne, Mol. Cryst. Liq. Cryst. 1985, 124,
[221] H. E. Zimmerman, R. D. McKelvey, J. Am. Chem. Soc. 1971, 93, 3638 – 105 – 114.
3645. [248] a) D. Demus, H.-J. Deutscher, F. Kuschel, H. Schubert, DDR Patent:
[222] a) R. A. Keller, L. J. Dolby, J. Am. Chem. Soc. 1969, 91, 1293 – 1299; 1974/105,701; b) D. Demus, Son-emissive Electrooptic Displays, Plenum,
b) S. A. Latt, H. T. Cheung, E. R. Blout, J. Am. Chem. Soc. 1965, 87, 995 – New York, 1976.
1003; c) A. A. Lamola, J. Am. Chem. Soc. 1969, 91, 4786 – 4790. [249] G. W. Gray, S. M. Kelly, J. Chem. Soc. Perkin Trans. 2 1981, 26 – 31.
[223] H. E. Zimmerman, R. K. King, M. B. Meinhardt, J. Org. Chem. 1992, 57, [250] G. W. Gray, S. M. Kelly, J. Chem. Soc. Chem. Commun. 1979, 974 – 975.
5484 – 5492. [251] a) G. W. Gray, S. M. Kelly, Angew. Chem. Int. Ed. Engl. 1981, 20, 393 –
[224] a) D. J. Wold, R. Haag, M. A. Rampi, C. D. Frisbie, J. Phys. Chem. B 2002, 394; Angew. Chem. 1981, 93, 412 – 415; b) G. W. Gray, Advances in
106, 2813 – 2816; b) T. Ishida, W. Mizutani, Y. Aya, H. Ogiso, S. Sasaki, H. Liquid Crystals, Academic Press, New York, 1976.
Tokumoto, J. Phys. Chem. B 2002, 106, 5886 – 5892. [252] G. W. Gray, S. M. Kelly, Mol. Cryst. Liq. Cryst. 1981, 75, 95 – 108.
[225] B. Schlicke, P. Belser, L. de Cola, E. Sabbioni, V. Balzani, J. Am. Chem. [253] G. W. Gray, S. M. Kelly, J. Mater. Chem. 1999, 9, 2037 – 2050.
Soc. 1999, 121, 4207 – 4214. [254] H. J. Deutscher, R. Frach, C. Tschierske, H. Zaschke, in Selected Topics in
[226] a) E. A. Weiss, M. J. Ahrens, L. E. Sinks, A. V. Gusev, M. A. Ratner, M. R. Liquid Crystal Research (Ed.: H.-D. Koswig), Akademie, Berlin, 1990.
Wasielewski, J. Am. Chem. Soc. 2004, 126, 5577 – 5584; b) W. Wang, S. [255] P. Kaszynski, A. Januszko, K. Ohta, T. Nagamine, P. Potaczek, V. G.
Wang, X. Li, J.-P. Collin, J. Liu, P. N. Liu, N. Lin, J. Am. Chem. Soc. 2010, Young, Y. Endo, Liq. Cryst. 2008, 35, 1169 – 1190.
132, 8774 – 8778. [256] A. Jankowiak, P. Kaszynski, W. R. Tilford, K. Ohta, A. Januszko, T. Naga-
[227] B. O. Jahn, H. Ottosson, M. Galperin, J. Fransson, ACS Nano 2013, 7, mine, Y. Endo, Beilstein J. Org. Chem. 2009, 5, 83.
1064 – 1071. [257] G. W. Gray, M. Hird, K. J. Toyne, Mol. Cryst. Liq. Cryst. 1991, 204, 91 –
[228] K. E. Drexler, Nanosystems: Moleculur Machinery, Manufacturing and 110.
Computation, Wiley, New York, 1992. [258] R. C. Geivandov, V. Mezhnev, T. Geivandova, Mol. Cryst. Liq. Cryst. 2011,
[229] F. Vçgtle, M. Frank, P. Belser, A. von Zelewsky, V. Balzani, L. de Cola, F. 542, 106 – 114.
Barigelletti, L. Flamigni, M. Nieger, Angew. Chem. Int. Ed. Engl. 1993, 32, [259] a) A. Januszko, K. L. Glab, P. Kaszynski, K. Patel, R. A. Lewis, G. H. Mehl,
1643 – 1646; Angew. Chem. 1993, 105, 1706 – 1709. M. D. Wand, J. Mater. Chem. 2006, 16, 3183 – 3192; b) M. Jasinski, A.
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4643 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
Jankowiak, A. Januszko, M. Bremer, D. Pauluth, P. Kaszynski, Liq. Cryst. [296] F. Ch8rioux, O. Galangau, F. Palmino, G. Rapenne, ChemPhysChem
2008, 35, 343 – 350. 2016, 17, 1742 – 1751.
[260] A. Januszko, K. L. Glab, P. Kaszynski, Liq. Cryst. 2008, 35, 549 – 553. [297] X. Jiang, B. Rodr&guez-Molina, N. Nazarian, M. A. Garcia-Garibay, J. Am.
[261] A. de Meijere, M. Messner, V. Vill, Mol. Cryst. Liq. Cryst. Sci. Technol. Sect. Chem. Soc. 2014, 136, 8871 – 8874.
A 1994, 257, 161 – 167. [298] G. Jimenez-Bueno, G. Rapenne, Tetrahedron Lett. 2003, 44, 6261 – 6263.
[262] C. Ramireddy, V. S. Reddy, P. Munk, C. N. Wu, Macromolecules 1991, 24, [299] G. Rapenne, G. Jimenez-Bueno, Tetrahedron 2007, 63, 7018 – 7026.
1387 – 1391. [300] H.-P. Jacquot de Rouville, R. Garbage, R. E. Cook, A. R. Pujol, A. M.
[263] K. J. Toyne, Thermotropic Liquid Crystals, Wiley, New York, 1987. Sirven, G. Rapenne, Chem. Eur. J. 2012, 18, 3023 – 3031.
[264] P. Kaszynski, A. C. Friedli, J. Michl, Mol. Cryst. Liq. Cryst. Lett. 1988, 6, [301] C. Lemouchi, H. M. Yamamoto, R. Kato, S. Simonov, L. Zorina, A. Rodr&-
27 – 33. guez-Fortea, E. Canadell, P. Wzietek, K. Iliopoulos, D. Gindre, M.
[265] V. Reiffenrath, F. Z. Schneider, Z. Naturforsch. 1981, 36a, 1006 – 1008. Chrysos, P. Batail, Cryst. Growth Des. 2014, 14, 3375 – 3383.
[266] S. S. Kuduva, D. C. Craig, A. Nangia, G. R. Desiraju, J. Am. Chem. Soc. [302] C. E. Godinez, G. Zepeda, M. A. Garcia-Garibay, J. Am. Chem. Soc. 2002,
1999, 121, 1936 – 1944. 124, 4701 – 4707.
[267] D. Das, R. K. R. Jetti, R. Boese, G. R. Desiraju, Cryst. Growth Des. 2003, 3, [303] C. E. Godinez, G. Zepeda, C. J. Mortko, H. Dang, M. A. Garcia-Garibay, J.
675 – 681. Org. Chem. 2004, 69, 1652 – 1662.
[268] S. S. Kuduva, D. Bl-ser, R. Boese, G. R. Desiraju, J. Org. Chem. 2001, 66, [304] S. D. Karlen, C. E. Godinez, M. A. Garcia-Garibay, Org. Lett. 2006, 8,
1621 – 1626. 3417 – 3420.
[269] J. Echeverr&a, G. Aulljn, D. Danovich, S. Shaik, S. Alvarez, Nat. Chem. [305] C. S. Vogelsberg, M. A. Garcia-Garibay, Chem. Soc. Rev. 2012, 41, 1892 –
2011, 3, 323 – 330. 1910.
[270] S. Pekker, E. Kov#ts, G. Oszl#nyi, G. B8nyei, G. Klupp, G. Bortel, I. Jal- [306] B. Rodr&guez-Molina, S. P8rez-Estrada, M. A. Garcia-Garibay, J. Am.
sovszky, E. Jakab, F. Borondics, K. Kamar#s, M. Bokor, G. Kriza, K. Chem. Soc. 2013, 135, 10388 – 10395.
Tompa, G. Faigel, Nat. Mater. 2005, 4, 764 – 767. [307] M. A. Garcia-Garibay, Proc. Natl. Acad. Sci. USA 2005, 102, 10771 –
[271] G. Bortel, S. Pekker, P. Kov#ts, Cryst. Growth Des. 2011, 11, 865 – 874. 10776.
[272] a) R. Freudenberger, W. Lamer, A. D. Schlueter, J. Org. Chem. 1993, 58, [308] a) T.-A. V. Khuong, G. Zepeda, R. Ruiz, S. I. Khan, M. A. Garcia-Garibay,
6497 – 6498; b) P. Kaszynski, J. Michl, J. Am. Chem. Soc. 1988, 110, Cryst. Growth Des. 2004, 4, 15 – 18; b) M. A. Garcia-Garibay, C. E. Godi-
5225 – 5226. nez, Cryst. Growth Des. 2009, 9, 3124 – 3128.
[273] P. Kaszynski, A. C. Friedli, J. Michl, J. Am. Chem. Soc. 1992, 114, 601 – [309] A. V. Akimov, A. B. Kolomeisky, J. Phys. Chem. C 2011, 115, 13584 –
620. 13591.
[274] H. Bothe, A.-D. Schleter, Adv. Mater. 1991, 3, 440 – 442. [310] K. Nikitin, H. Meller-Bunz, Y. Ortin, W. Risse, M. J. McGlinchey, Eur. J.
[275] J. D. D. Rehm, B. Ziemer, G. Szeimies, Eur. J. Org. Chem. 2001, 1049 – Org. Chem. 2008, 3079 – 3084.
1052. [311] S. Toyota, T. Shimizu, T. Iwanaga, K. Wakamatsu, Chem. Lett. 2011, 40,
[276] C. Mazal, A. J. Paraskos, J. Michl, J. Org. Chem. 1998, 63, 2116 – 2119. 312 – 314.
[277] J. Kaleta, Z. Janoušek, M. Nečas, C. Mazal, Organometallics 2015, 34, [312] D. K. Frantz, A. Linden, K. K. Baldridge, J. S. Siegel, J. Am. Chem. Soc.
967 – 972. 2012, 134, 1528 – 1535.
[278] P. F. H. Schwab, B. C. Noll, J. Michl, J. Org. Chem. 2002, 67, 5476 – 5485. [313] F. Huang, G. Wang, L. Ma, Y. Wang, X. Chen, Y. Che, H. Jiang, J. Org.
[279] G. Nuding, F. Voegtle, K. Danielmeier, E. Steckhan, Synthesis 1996, 71 – Chem. 2017, 82, 12106 – 12111.
76. [314] A. M. Stevens, C. J. Richards, Tetrahedron Lett. 1997, 38, 7805 – 7808.
[280] P. E. Eaton, E. Galoppini, R. Gilardi, J. Am. Chem. Soc. 1994, 116, 7588 – [315] M. Oki, Angew. Chem. Int. Ed. Engl. 1976, 15, 87 – 93; Angew. Chem.
7596. 1976, 88, 67 – 74.
[281] P. E. Eaton, K. Pramod, T. Emrick, R. Gilardi, J. Am. Chem. Soc. 1999, 121, [316] S. Toyota, K. Kawahata, K. Sugahara, K. Wakamatsu, T. Iwanaga, Eur. J.
4111 – 4123. Org. Chem. 2017, 5696 – 5707.
[282] Y. Chauvin, L. Saussine, Macromolecules 1996, 29, 1163 – 1166. [317] G. Wang, H. Xiao, J. He, J. Xiang, Y. Wang, X. Chen, Y. Che, H. Jiang, J.
[283] T. Kakuchi, W. Hirahat, S. Yano, H. Kaga, Polym. Bull. 1997, 38, 651 – Org. Chem. 2016, 81, 3364 – 3371.
655. [318] T. R. Kelly, M. C. Bowyer, K. V. Bhaskar, D. Bebbington, A. Garcia, F. Lang,
[284] R. Priefer, S. Nguyen, P. G. Farrell, D. N. Harpp, Macromolecules 2003, M. H. Kim, M. P. Jette, J. Am. Chem. Soc. 1994, 116, 3657 – 3658.
36, 5435 – 5436. [319] T. R. Kelly, Acc. Chem. Res. 2001, 34, 514 – 522.
[285] N.-H. Yeh, C.-W. Chen, S.-L. Lee, H.-J. Wu, C.-h. Chen, T.-Y. Luh, Macro- [320] a) T. R. Kelly, J. P. Sestelo, I. Tellitu, J. Org. Chem. 1998, 63, 3655 – 3665;
molecules 2012, 45, 2662 – 2667. b) T. R. Kelly, I. Tellitu, J. P. Sestelo, Angew. Chem. Int. Ed. Engl. 1997, 36,
[286] P. I. Dron, K. Zhao, J. Kaleta, Y. Shen, J. Wen, R. K. Shoemaker, C. T. 1866 – 1868; Angew. Chem. 1997, 109, 1969 – 1972.
Rogers, J. Michl, Adv. Funct. Mater. 2016, 26, 5718 – 5732. [321] T. R. Kelly, H. de Silva, R. A. Silva, Nature 1999, 401, 150 – 152.
[287] C. Lemouchi, K. Iliopoulos, L. Zorina, S. Simonov, P. Wzietek, T. Cauchy, [322] a) K. Nikitin, H. Meller-Bunz, Y. Ortin, M. J. McGlinchey, Org. Biomol.
A. Rodr&guez-Fortea, E. Canadell, J. Kaleta, J. Michl, D. Gindre, M. Chem. 2007, 5, 1952 – 1960; b) K. Nikitin, C. Fleming, H. Meller-Bunz, Y.
Chrysos, P. Batail, J. Am. Chem. Soc. 2013, 135, 9366 – 9376. Ortin, M. J. McGlinchey, Eur. J. Org. Chem. 2010, 5203 – 5216; c) L. E.
[288] G. Bastien, C. Lemouchi, P. Wzietek, S. Simonov, L. Zorina, A. Rodr&- Harrington, L. S. Cahill, M. J. McGlinchey, Organometallics 2004, 23,
guez-Fortea, E. Canadell, P. Batail, Z. Anorg. Allg. Chem. 2014, 640, 2884 – 2891; d) K. Nikitin, C. Bothe, H. Meller-Bunz, Y. Ortin, M. J.
1127 – 1133. McGlinchey, Organometallics 2012, 31, 6183 – 6198.
[289] J. Kaleta, J. Michl, C. M8ziHre, S. Simonov, L. Zorina, P. Wzietek, A. Ro- [323] K. Nikitin, H. Meller-Bunz, Y. Ortin, J. Muldoon, M. J. McGlinchey, J. Am.
dr&guez-Fortea, E. Canadell, P. Batail, CrystEngComm 2015, 17, 7829 – Chem. Soc. 2010, 132, 17617 – 17622.
7834. [324] K. Nikitin, J. Muldoon, H. Meller-Bunz, M. J. McGlinchey, Chem. Eur. J.
[290] C. Lemouchi, P. Batail, Beilstein J. Org. Chem. 2015, 11, 1881 – 1885. 2015, 21, 4664 – 4670.
[291] J. Kaleta, G. Bastien, I. C&sařov#, P. Batail, J. Michl, Eur. J. Org. Chem. [325] M. O’Keeffe, O. M. Yaghi, Chem. Rev. 2012, 112, 675 – 702.
2018, 5137 – 5142. [326] R. Ballesteros-Garrido, A. P. da Costa, P. Atienzar, M. Alvaro, C. Baleiz¼o,
[292] H. Iwamura, K. Mislow, Acc. Chem. Res. 1988, 21, 175 – 182. H. Garc&a, RSC Adv. 2016, 6, 35191 – 35196.
[293] Y. Kawada, H. Sakai, M. Oguri, G. Koga, Tetrahedron Lett. 1994, 35, [327] P. J. Llabres-Campaner, J. Pitarch-Jarque, R. Ballesteros-Garrido, B.
139 – 142. Abarca, R. Ballesteros, E. Garc&a-EspaÇa, Dalton Trans. 2017, 46, 7397 –
[294] a) Nobel Prize (2016) The Nobel Prize in Chemistry. Available at 7402.
www.nobelprize.org/nobel_prizes/chemistry/laureates/2016/; Accessed [328] X. Jiang, H.-B. Duan, S. I. Khan, M. A. Garcia-Garibay, ACS Cent. Sci.
November 20, 2016; b) D. A. Leigh, Angew. Chem. Int. Ed. 2016, 55, 2016, 2, 608 – 613.
14506 – 14508; Angew. Chem. 2016, 128, 14722 – 14724. [329] a) S. I. Vagin, A. K. Ott, S. D. Hoffmann, D. Lanzinger, B. Rieger, Chem.
[295] J. E. Walker, Angew. Chem. Int. Ed. 1998, 37, 2308 – 2319; Angew. Chem. Eur. J. 2009, 15, 5845 – 5853; b) S. Vagin, A. Ott, H.-C. Weiss, A. Karbach,
1998, 110, 2438 – 2450. D. Volkmer, B. Rieger, Eur. J. Inorg. Chem. 2008, 2601 – 2609.
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4644 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
[330] a) H. Chun, D. N. Dybtsev, H. Kim, K. Kim, Chem. Eur. J. 2005, 11, 3521 – [356] Y. L. Goh, Y. T. Cui, V. Pendharkar, V. A. Adsool, ACS Med. Chem. Lett.
3529; b) B.-Q. Ma, K. L. Mulfort, J. T. Hupp, Inorg. Chem. 2005, 44, 2017, 8, 516 – 520.
4912 – 4914. [357] N. T. Thirumoorthi, V. A. Adsool, Org. Biomol. Chem. 2016, 14, 9485 –
[331] E. I. Volkova, A. V. Vakhrushev, M. Suyetin, Chem. Phys. 2015, 459, 14 – 9489.
18. [358] a) A. Levitzki, E. Mishani, Annu. Rev. Biochem. 2006, 75, 93 – 109; b) T.
[332] A. Kuc, A. Enyashin, G. Seifert, J. Phys. Chem. B 2007, 111, 8179 – 8186. Hunter, J. Clin. Invest. 2007, 117, 2036 – 2043.
[333] a) M. R. P8rez, I. Pavlovic, C. Barriga, J. Cornejo, M. C. Hermos&n, M. A. [359] V. M. Richon, Br. J. Cancer 2006, 95, S2 – S6.
Ulibarri, Appl. Clay Sci. 2006, 32, 245 – 251; b) F. Cavani, F. Trifirb, A. Vac- [360] P. J. Middlemiss, A. J. Glasky, M. P. Rathbone, E. Werstuik, S. Hindley, J.
cari, Catal. Today 1991, 11, 173 – 301. Gysbers, Neurosci. Lett. 1995, 199, 131 – 134.
[334] a) F. A. Rad, Z. Rezvani, RSC Adv. 2015, 5, 67384 – 67393; b) Z. Rezvani, [361] M. J. O’Neil, The Merck Index: An Encyclopedia of Chemicals, Drugs, and
F. Arjomandi Rad, F. Khodam, Dalton Trans. 2015, 44, 988 – 996. Biologicals, RSC, Cambridge, 2013.
[335] F. A. Cotton, L. M. Daniels, C. Lin, C. A. Murillo, S.-Y. Yu, J. Chem. Soc. [362] M. R. Barbachyn, D. K. Hutchinson, D. S. Toops, R. J. Reid, G. E. Zurenko,
Dalton Trans. 2001, 502 – 504. B. H. Yagi, R. D. Schaadt, J. W. Allison, Bioorg. Med. Chem. Lett. 1993, 3,
[336] a) A. F. Stepan, C. Subramanyam, I. V. Efremov, J. K. Dutra, T. J. O’Sulli- 671 – 676.
van, K. J. DiRico, W. S. McDonald, A. Won, P. H. Dorff, C. E. Nolan, S. L.
[363] D. Bouzard, P. Di Cesare, M. Essiz, J. P. Jacquet, J. R. Kiechel, P. Remu-
Becker, L. R. Pustilnik, D. R. Riddell, G. W. Kauffman, B. L. Kormos, L.
zon, A. Weber, T. Oki, M. Masuyoshi, R. E. Kessler, J. Med. Chem. 1990,
Zhang, Y. Lu, S. H. Capetta, M. E. Green, K. Karki, E. Sibley, K. P. Atchi-
33, 1344 – 1352.
son, A. J. Hallgren, C. E. Oborski, A. E. Robshaw, B. Sneed, C. J. O’Don-
[364] L. J. Rubin, D. B. Badesch, R. J. Barst, N. Galie, C. M. Black, A. Keogh, T.
nell, J. Med. Chem. 2012, 55, 3414 – 3424; b) K. C. Nicolaou, D. Vourlou-
Pulido, A. Frost, S. Roux, I. Leconte, M. Landzberg, G. Simonneau, New
mis, S. Totokotsopoulos, A. Papakyriakou, H. Karsunky, H. Fernando, J.
Engl. J. Med. 2002, 346, 896 – 903.
Gavrilyuk, D. Webb, A. F. Stepan, ChemMedChem 2016, 11, 31 – 37.
[365] K. O. Arseneau, F. Cominelli, Expert Opin. Invest. Drugs 2013, 22, 907 –
[337] For a recent comprehensive review on this topic, see: T. A. Reekie,
913.
C. M. Williams, L. M. Rendina, M. Kassiou, J. Med. Chem. 2018, in press,
[366] M. V. Westphal, B. T. Wolfst-dter, J.-M. Plancher, J. Gatfield, E. M. Car-
DOI https://doi.org/10.1021/acs.jmedchem.8b00888.
[338] N. A. Meanwell, J. Med. Chem. 2011, 54, 2529 – 2591. reira, ChemMedChem 2015, 10, 461 – 469.
[339] T. J. Ritchie, S. J. F. Macdonald, Drug Discovery Today 2009, 14, 1011 – [367] J. M. Lopchuk, K. Fjelbye, Y. Kawamata, L. R. Malins, C.-M. Pan, R. Giana-
1020. tassio, J. Wang, L. Prieto, J. Bradow, T. A. Brandt, M. R. Collins, J. Eller-
[340] N. T. Thirumoorthi, C. Jia Shen, V. A. Adsool, Chem. Commun. 2015, 51, aas, J. Ewanicki, W. Farrell, O. O. Fadeyi, G. M. Gallego, J. J. Mousseau,
3139 – 3142. R. Oliver, N. W. Sach, J. K. Smith, J. E. Spangler, H. Zhu, J. Zhu, P. S.
[341] D. E. Applequist, T. L. Renken, J. W. Wheeler, J. Org. Chem. 1982, 47, Baran, J. Am. Chem. Soc. 2017, 139, 3209 – 3226.
4985 – 4995. [368] L. Zehnder, M. Bennett, J. Meng, B. Huang, S. Ninkovic, F. Wang, J. Bra-
[342] a) Y. P. Auberson, E. Briard, D. Sykes, J. Reilly, M. Healy, ChemMedChem ganza, J. Tatlock, T. Jewell, J. Z. Zhou, B. Burke, J. Wang, K. Maegley,
2016, 11, 1415 – 1427; b) F. Assmus, A. Seelig, L. Gobbi, E. Borroni, P. P. P. Mehta, M.-J. Yin, K. S. Gajiwala, M. J. Hickey, S. Yamazaki, E. Smith,
Glaentzlin, H. Fischer, Eur. J. Pharm. Sci. 2015, 79, 27 – 35. P. Kang, A. Sistla, E. Dovalsantos, M. R. Gehring, R. Kania, M. Wythes, P.-
[343] R. C. Reynolds, C. A. Johnson, J. R. Piper, F. M. Sirotnak, Eur. J. Med. P. Kung, J. Med. Chem. 2011, 54, 3368 – 3385.
Chem. 2001, 36, 237 – 242. [369] a) A. Pagano, D. Ruegg, S. Litschig, N. Stoehr, C. Stierlin, M. Heinrich, P.
[344] A. Rosowsky, in Progress in Medicinal Chemistry, Vol. 29 (Eds.: G. P. Ellis, Floersheim, L. PrezHau, F. Carroll, J. P. Pin, A. Cambria, I. Vranesic, P. Jo-
G. B. West), Elsevier, Amsterdam, 1989, pp. 1 – 252. sef Flor, F. Gasparini, R. Kuhn, J. Biol. Chem. 2000, 275, 33750 – 33758;
[345] a) S. Sinha, I. Lieberburg, Proc. Natl. Acad. Sci. USA 1999, 96, 11049 – b) P. M. Lea, A. I. Faden, CNS Drug Rev. 2006, 12, 149 – 166.
11053; b) B. A. Bergmans, B. de Strooper, Lancet Neurol. 2010, 9, 215 – [370] C.-Y. Cheng, L.-W. Hsin, Y.-P. Lin, P.-L. Tao, T.-T. Jong, Bioorg. Med. Chem.
226; c) M. S. Wolfe, Biochemistry 2006, 45, 7931 – 7939. 1996, 4, 73 – 80.
[346] a) R. Kopan, M. X. G. Ilagan, Nat. Rev. Mol. Cell Biol. 2004, 5, 499 – 504; [371] a) B. Sperl#gh, P. Illes, Purinergic Signal. 2007, 3, 117 – 127; b) J. P.
b) A. J. Beel, C. R. Sanders, Cell. Mol. Life Sci. 2008, 65, 1311 – 1334. Hughes, J. P. Hatcher, I. P. Chessell, Purinergic Signal. 2007, 3, 163 – 169.
[347] a) A. F. Kreft, R. Martone, A. Porte, J. Med. Chem. 2009, 52, 6169 – 6188; [372] K. Inoue, Purinergic Signal. 2007, 3, 135 – 144.
b) R. E. Olson, C. F. Albright, Curr. Top. Med. Chem. 2008, 8, 17 – 33; [373] H. Gunosewoyo, J. L. Guo, M. R. Bennett, M. J. Coster, M. Kassiou,
c) K. W. Gillman, J. E. Starrett, M. F. Parker, K. Xie, J. J. Bronson, L. R. Bioorg. Med. Chem. Lett. 2008, 18, 3720 – 3723.
Marcin, K. E. McElhone, C. P. Bergstrom, R. A. Mate, R. Williams, J. E. [374] V. A. Zammit, L. K. Buckett, A. V. Turnbull, H. Wure, A. Proven, Pharma-
Meredith, Jr., C. R. Burton, D. M. Barten, J. H. Toyn, S. B. Roberts, K. A. col. Ther. 2008, 118, 295 – 302.
Lentz, J. G. Houston, R. Zaczek, C. F. Albright, C. P. Decicco, J. E. Macor, [375] B. M. Fox, N. Furukawa, X. Hao, K. Iio, T. Inaba, S. M. Jackson, F. Kayser,
R. E. Olson, ACS Med. Chem. Lett. 2010, 1, 120 – 124. M. Labelle, K. Li, T. Matsui, D. L. Mcminn, N. Ogawa, S. M. Rubenstein,
[348] a) G. Staurenghi, L. Ye, M. H. Magee, R. P. Danis, J. Wurzelmann, P. S. Sagawa, K. Sugimoto, M. Suzuki, M. Tanaka, G. Ye, A. Yoshida, J.
Adamson, M. M. McLaughlin, Ophthalmology 2015, 122, 990 – 996;
Zhang (Tularik Inc & Japan Tobacco Inc) U.S. & Japan Patent WO
b) G. Maher-Edwards, J. De’Ath, C. Barnett, A. Lavrov, A. Lockhart, Alz-
2004047755.
heimer’s Dementia 2015, 1, 131 – 140.
[376] A. V. Stachulski, J. R. Harding, J. C. Lindon, J. L. Maggs, B. K. Park, I. D.
[349] J. A. Blackie, J. C. Bloomer, M. J. B. Brown, H. Y. Cheng, B. Hammond,
Wilson, J. Med. Chem. 2006, 49, 6931 – 6945.
D. M. B. Hickey, R. J. Ife, C. A. Leach, V. A. Lewis, C. H. Macphee, K. J. Mil-
[377] A. M. Birch, S. Birtles, L. K. Buckett, P. D. Kemmitt, G. J. Smith, T. J. D.
liner, K. E. Moores, I. L. Pinto, S. A. Smith, I. G. Stansfield, S. J. Stanway,
Smith, A. V. Turnbull, S. J. Y. Wang, J. Med. Chem. 2009, 52, 1558 – 1568.
M. A. Taylor, C. J. Theobald, Bioorg. Med. Chem. Lett. 2003, 13, 1067 –
[378] J. G. Barlind, U. A. Bauer, A. M. Birch, S. Birtles, L. K. Buckett, R. J. Butlin,
1070.
R. D. M. Davies, J. W. Eriksson, C. D. Hammond, R. Hovland, P. Johan-
[350] R. J. Young, D. V. S. Green, C. N. Luscombe, A. P. Hill, Drug Discovery
Today 2011, 16, 822 – 830. nesson, M. J. Johansson, P. D. Kemmitt, B. T. Lindmark, P. M. Gutierrez,
[351] N. D. Measom, K. D. Down, D. J. Hirst, C. Jamieson, E. S. Manas, V. K. T. A. Noeske, A. Nordin, C. J. O’Donnell, A. U. Petersson, A. Redzic, A. V.
Patel, D. O. Somers, ACS Med. Chem. Lett. 2017, 8, 43 – 48. Turnbull, J. Vinblad, J. Med. Chem. 2012, 55, 10610 – 10629.
[352] M. H. Keylor, B. S. Matsuura, C. R. J. Stephenson, Chem. Rev. 2015, 115, [379] F. Cameron, M. Sanford, Drugs 2014, 74, 263 – 271.
8976 – 9027. [380] B. B. Lerman, L. Belardinelli, Circulation 1991, 83, 1499 – 1509.
[353] L. G. Carter, J. A. D’Orazio, K. J. Pearson, Endocr.-Relat. Cancer 2014, 21, [381] X. Gao, J. Wang, J. Liu, D. Guiadeen, A. Krikorian, S. B. Boga, A.-B. Alhas-
R209 – 225. san, O. Selyutin, W. Yu, Y. Yu, R. Anand, S. Liu, C. Yang, H. Wu, J. Cai, A.
[354] J. M. Smoliga, O. Blanchard, Molecules 2014, 19, 17154 – 17172. Cooper, H. Zhu, K. Maloney, Y.-D. Gao, T. O. Fischmann, J. Presland, M.
[355] L. A. Stivala, M. Savio, F. Carafoli, P. Perucca, L. Bianchi, G. Maga, L. Mansueto, Z. Xu, E. Leccese, J. Zhang-Hoover, I. Knemeyer, C. G. Garlisi,
Forti, U. M. Pagnoni, A. Albini, E. Prosperi, V. Vannini, J. Biol. Chem. N. Bays, P. Stivers, P. E. Brandish, A. Hicks, R. Kim, J. A. Kozlowski,
2001, 276, 22586 – 22594. Bioorg. Med. Chem. Lett. 2017, 27, 1471 – 1477.
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4645 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
[382] R. Al Hussainy, J. Verbeek, D. van der Born, A. H. Braker, J. E. Leysen, [413] P. K. Mikhailiuk, S. Afonin, A. N. Chernega, E. B. Rusanov, M. O. Platonov,
R. J. Knol, J. Booij, J. K. D. M. Herscheid, J. Med. Chem. 2011, 54, 3480 – G. G. Dubinina, M. Berditsch, A. S. Ulrich, I. V. Komarov, Angew. Chem.
3491. Int. Ed. 2006, 45, 5659 – 5661; Angew. Chem. 2006, 118, 5787 – 5789.
[383] a) R. Al Hussainy, J. Verbeek, D. van der Born, J. Booij, J. K. D. M. Hersc- [414] S. L. Grage, X. Xu, M. Schmitt, P. Wadhwani, A. S. Ulrich, J. Phys. Chem.
heid, Eur. J. Med. Chem. 2011, 46, 5728 – 5735; b) R. Al Hussainy, J. Ver- Lett. 2014, 5, 4256 – 4259.
beek, D. van der Born, C. Molthoff, J. Booij, J. K. D. M. Herscheid, Nucl. [415] a) O. Toke, R. D. O’Connor, T. K. Weldeghiorghis, W. L. Maloy, R. W.
Med. Biol. 2012, 39, 1068 – 1076. Glaser, A. S. Ulrich, J. Schaefer, Biophys. J. 2004, 87, 675 – 687; b) J. Sal-
[384] G. Reaven, Circulation 2002, 106, 286 – 288. gado, S. L. Grage, L. H. Kondejewski, R. S. Hodges, R. N. McElhaney,
[385] J. R. Seckl, B. R. Walker, Endocrinology 2001, 142, 1371 – 1376. A. S. Ulrich, J. Biomol. NMR 2001, 21, 191 – 208; c) A. N. Tkachenko, P. K.
[386] a) X. Gu, J. Dragovic, G. C. Koo, S. L. Koprak, C. LeGrand, S. S. Mundt, K. Mykhailiuk, D. S. Radchenko, O. Babii, S. Afonin, A. S. Ulrich, I. V. Komar-
Shah, M. S. Springer, E. Y. Tan, R. Thieringer, A. Hermanowski-Vosatka, ov, Eur. J. Org. Chem. 2014, 3584 – 3591.
H. J. Zokian, J. M. Balkovec, S. T. Waddell, Bioorg. Med. Chem. Lett. [416] D. Bandak, O. Babii, R. Vasiuta, I. V. Komarov, P. K. Mykhailiuk, Org. Lett.
2005, 15, 5266 – 5269; b) M. Maletic, A. Leeman, M. Szymonifka, S. S. 2015, 17, 226 – 229.
Mundt, H. J. Zokian, K. Shah, J. Dragovic, K. Lyons, R. Thieringer, A. H. [417] K. Richter, H. Aschauer, G. Kreil, Peptides 1985, 6, 17 – 21.
Vosatka, J. Balkovec, S. T. Waddell, Bioorg. Med. Chem. Lett. 2011, 21, [418] K. Schmidt-Rohr, E. R. deAzevedo, T. J. Bonagamba, in Centerband-Only
2568 – 2572. Detection of Exchange (CODEX), Wiley, Chichester, 2007.
[387] S. T. Waddell, G. M. Santorelli, M. M. Milana, A. H. Leeman, X. Gu, D. W. [419] a) E. Strandberg, P. Wadhwani, P. Tremouilhac, U. H. N. Derr, A. S. Ulrich,
Graham, J. M. Balkovec, S. D. Aster (Merck & Co Inc.) US Patent: US Biophys. J. 2006, 90, 1676 – 1686; b) D. S. Radchenko, S. Kattge, S. Kara,
2004133011 (A1). A. S. Ulrich, S. Afonin, Biochim. Biophys. Acta Biomembr. 2016, 1858,
[388] W. A. Gregory (E. I. du Pont de Nemours and Co.) US Patent 3558704. 2019 – 2027.
[389] F. Bordi, A. Ugolini, Prog. Neurobiol. 1999, 59, 55 – 79. [420] S. Horvat, K. Mlinarić-Majerski, L. Glavas-Obrovac, A. Jakas, J. Veljković,
[390] J. P. Pin, R. Duvoisin, Neuropharmacology 1995, 34, 1 – 26. S. Marczi, G. Kragol, M. Roscić, M. Matković, A. Milostić-Srb, J. Med.
[391] S. A. Eaton, D. E. Jane, P. L. St. J. Jones, R. H. P. Porter, P. C.-K. Pook, Chem. 2006, 49, 3136 – 3142.
D. C. Sunter, P. M. Udvarhelyi, P. J. Roberts, T. E. Salt, J. C. Watkins, Eur. J. [421] V. V. Kapoerchan, A. D. Knijnenburg, M. Niamat, E. Spalburg, A. J. de
Pharmacol. 1993, 244, 195 – 197. Neeling, P. H. Nibbering, R. H. Mars-Groenendijk, D. Noort, J. M. Otero,
[392] J. Watkins, G. Collingridge, Trends Pharmacol. Sci. 1994, 15, 333 – 342. A. L. Llamas-Saiz, M. J. van Raaij, G. A. van der Marel, H. S. Overkleeft,
[393] R. Pellicciari, M. Raimondo, M. Marinozzi, B. Natalini, G. Costantino, C. M. Overhand, Chem. Eur. J. 2010, 16, 12174 – 12181.
Thomsen, J. Med. Chem. 1996, 39, 2874 – 2876. [422] K. C. Nicolaou, J. Yin, D. Mandal, R. D. Erande, P. Klahn, M. Jin, M. Aujay,
[394] R. Pellicciari, G. Costantino, E. Giovagnoni, L. Mattoli, I. Brabet, J.-P. Pin, J. Sandoval, J. Gavrilyuk, D. Vourloumis, J. Am. Chem. Soc. 2016, 138,
1698 – 1708.
Bioorg. Med. Chem. Lett. 1998, 8, 1569 – 1574.
[423] a) P. Gaudreau, R. Quirion, S. St-Pierre, C. B. Pert, Peptides 1983, 4, 755 –
[395] S. R. Baker, T. C. Hancox, Tetrahedron Lett. 1999, 40, 781 – 784.
762; b) M. P-tzel, M. Sanktjohanser, A. Doss, P. Henklein, G. Szeimies,
[396] G. Costantino, K. Maltoni, M. Marinozzi, E. Camaioni, L. Prezeau, J.-P.
Eur. J. Org. Chem. 2004, 493 – 498.
Pin, R. Pellicciari, Bioorg. Med. Chem. 2001, 9, 221 – 227.
[424] S. E. Blondelle, E. Takahashi, K. T. Dinh, R. A. Houghten, J. Appl. Bacter-
[397] R. Pellicciari, R. Filosa, M. C. Fulco, M. Marinozzi, A. Macchiarulo, C.
iol. 1995, 78, 39 – 46.
Novak, B. Natalini, M. B. Hermit, S. Nielsen, T. N. Sager, T. B. Stensbøl, C.
[425] S. Pritz, M. P-tzel, G. Szeimies, M. Dathe, M. Bienert, Org. Biomol. Chem.
Thomsen, ChemMedChem 2006, 1, 358 – 365.
2007, 5, 1789 – 1794.
[398] Y. Tanabe, A. Nomura, M. Masu, R. Shigemoto, N. Mizuno, S. Nakanishi,
[426] A. Wessolowski, M. Bienert, M. Dathe, J. Pept. Res. 2004, 64, 159 – 169.
J. Neurosci. 1993, 13, 1372 – 1378.
[427] E. Selva, G. Beretta, N. Montanini, G. S. Saddler, L. Gastaldo, P. Ferrari,
[399] a) R. Filosa, M. Marinozzi, G. Costantino, M. B. Hermit, C. Thomsen, R.
R. Lorenzetti, P. Landini, F. Ripamonti, B. P. Goldstein, J. Antibiot. 1991,
Pellicciari, Bioorg. Med. Chem. 2006, 14, 3811 – 3817; b) R. Filosa, M. Car-
44, 693 – 701.
mela Fulco, M. Marinozzi, N. GiacchH, A. Macchiarulo, A. Peduto, A.
[428] M. J. LaMarche, J. A. Leeds, K. Amaral, J. T. Brewer, S. M. Bushell, J. M.
Massa, P. de Caprariis, C. Thomsen, C. T. Christoffersen, R. Pellicciari,
Dewhurst, J. Dzink-Fox, E. Gangl, J. Goldovitz, A. Jain, S. Mullin, G.
Bioorg. Med. Chem. 2009, 17, 242 – 250.
Neckermann, C. Osborne, D. Palestrant, M. A. Patane, E. M. Rann, M.
[400] L. J. Loeffler, S. F. Britcher, W. Baumgarten, J. Med. Chem. 1970, 13,
Sachdeva, J. Shao, S. Tiamfook, L. Whitehead, D. Yu, J. Med. Chem.
926 – 935.
2011, 54, 8099 – 8109.
[401] J. Wlochal, R. Davies, J. Burton, Synlett 2016, 27, 919 – 923.
[429] a) Q. L. Choo, G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, M.
[402] Q. I. Churches, R. J. Mulder, J. M. White, J. Tsanaktsidis, P. J. Duggan,
Houghton, Science 1989, 244, 359 – 362; b) G. Kuo, Q. L. Choo, H. J.
Aust. J. Chem. 2012, 65, 690 – 693. Alter, G. L. Gitnick, A. G. Redeker, R. H. Purcell, T. Miyamura, J. L. Dien-
[403] D. Steer, R. Lew, P. Perlmutter, A. I. Smith, M.-I. Aguilar, Biochemistry stag, M. J. Alter, C. E. Stevens, Science 1989, 244, 362 – 364.
2002, 41, 10819 – 10826. [430] A. Macdonald, M. Harris, J. Gen. Virol. 2004, 85, 2485 – 2502.
[404] D. Seebach, J. L. Matthews, Chem. Commun. 1997, 2015 – 2022. [431] J. L. Romine, D. R. St. Laurent, J. E. Leet, S. W. Martin, M. H. Serrano-
[405] M. A. Danielson, J. J. Falke, Annu. Rev. Biophys. Biomol. Struct. 1996, 25, Wu, F. Yang, M. Gao, D. R. O’Boyle, J. A. Lemm, J.-H. Sun, P. T. Nower,
163 – 195. X. S. Huang, M. S. Deshpande, N. A. Meanwell, L. B. Snyder, ACS Med.
[406] R. W. Glaser, C. Sachse, U. H. N. Derr, P. Wadhwani, S. Afonin, E. Strand- Chem. Lett. 2011, 2, 224 – 229.
berg, A. S. Ulrich, Biophys. J. 2005, 88, 3392 – 3397. [432] M. Gao, R. E. Nettles, M. Belema, L. B. Snyder, V. N. Nguyen, R. A. Fridell,
[407] R. W. Glaser, C. Sachse, U. H. N. Derr, P. Wadhwani, A. S. Ulrich, J. Magn. M. H. Serrano-Wu, D. R. Langley, J.-H. Sun, D. R. O’Boyle, J. A. Lemm, C.
Reson. 2004, 168, 153 – 163. Wang, J. O. Knipe, C. Chien, R. J. Colonno, D. M. Grasela, N. A. Mean-
[408] P. Wadhwani, J. Reichert, E. Strandberg, J. Berck, J. Misiewicz, S. Afonin, well, L. G. Hamann, Nature 2010, 465, 96 – 100.
N. Heidenreich, S. Fangh-nel, P. K. Mykhailiuk, I. V. Komarov, A. S. [433] M. Zhong, E. Peng, N. Huang, Q. Huang, A. Huq, M. Lau, R. Colonno, L.
Ulrich, Phys. Chem. Chem. Phys. 2013, 15, 8962 – 8971. Li, Bioorg. Med. Chem. Lett. 2016, 26, 4508 – 4512.
[409] P. Wadhwani, E. Strandberg, N. Heidenreich, J. Berck, S. Fangh-nel, [434] P. R. Schreiner, A. A. Fokin, O. Lauenstein, Y. Okamoto, T. Wakita, C. Rin-
A. S. Ulrich, J. Am. Chem. Soc. 2012, 134, 6512 – 6515. derspacher, G. H. Robinson, J. K. Vohs, C. F. Campana, J. Am. Chem. Soc.
[410] J. Blazyk, R. Wiegand, J. Klein, J. Hammer, R. M. Epand, R. F. Epand, 2002, 124, 13348 – 13349.
W. L. Maloy, U. P. Kari, J. Biol. Chem. 2001, 276, 27899 – 27906. [435] A. A. Fokin, P. R. Schreiner, R. Berger, G. H. Robinson, P. Wei, C. F. Cam-
[411] M. Meier, J. Seelig, J. Am. Chem. Soc. 2008, 130, 1017 – 1024. pana, J. Am. Chem. Soc. 2006, 128, 5332 – 5333.
[412] S. O. Kokhan, A. V. Tymtsunik, S. L. Grage, S. Afonin, O. Babii, M. Ber- [436] a) R. Chauvin, Tetrahedron Lett. 1995, 36, 397 – 400; b) V. Maraval, R.
ditsch, A. V. Strizhak, D. Bandak, M. O. Platonov, I. V. Komarov, A. S. Chauvin, New J. Chem. 2007, 31, 1853 – 1873.
Ulrich, P. K. Mykhailiuk, Angew. Chem. Int. Ed. 2016, 55, 14788 – 14792; [437] K. S. Feldman, C. M. Kraebel, M. Parvez, J. Am. Chem. Soc. 1993, 115,
Angew. Chem. 2016, 128, 15008 – 15012. 3846 – 3847.
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4646 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Review
[438] a) S. Szafert, J. A. Gladysz, Chem. Rev. 2006, 106, 1 – 33; b) A. Orita, J. [446] R. Hoffmann, H. Hopf, Angew. Chem. Int. Ed. 2008, 47, 4474 – 4481;
Otera, Chem. Rev. 2006, 106, 5387 – 5412. Angew. Chem. 2008, 120, 4548 – 4556.
[439] K. K. Larson, M. He, J. F. Teichert, A. Naganawa, J. W. Bode, Chem. Sci. [447] P. Dowd, H. Irngartinger, Chem. Rev. 1989, 89, 985 – 996.
2012, 3, 1825 – 1828. [448] L. A. Paquette, R. J. Ternansky, D. W. Balogh, G. Kentgen, J. Am. Chem.
[440] J. F. Teichert, D. Mazunin, J. W. Bode, J. Am. Chem. Soc. 2013, 135, Soc. 1983, 105, 5446 – 5450.
11314 – 11321. [449] G. J. Kent, S. A. Godleski, E. Osawa, P. v. R. Schleyer, J. Org. Chem. 1977,
[441] O. Yahiaoui, L. F. Pašteka, B. Judeel, T. Fallon, Angew. Chem. Int. Ed. 42, 3852 – 3859.
2018, 57, 2570 – 2574; Angew. Chem. 2018, 130, 2600 – 2604. [450] B. R. Vogt, S. R. Suter, J. R. E. Hoover, Tetrahedron Lett. 1968, 13, 1609 –
[442] P. C. M. van Gerven, J. A. A. W. Elemans, J. W. Gerritsen, S. Speller, 1612.
R. J. M. Nolte, A. E. Rowan, Chem. Commun. 2005, 3535 – 3537.
[443] Q. Wang, C. Yu, C. Zhang, H. Long, S. Azarnoush, Y. Jin, W. Zhang,
Chem. Sci. 2016, 7, 3370 – 3376.
Manuscript received: August 19, 2018
[444] J.-F. Xu, Y.-Z. Chen, L.-Z. Wu, C.-H. Tung, Q.-Z. Yang, Org. Lett. 2013, 15,
Revised manuscript received: October 20, 2018
6148 – 6151.
[445] Y. Jin, C. Yu, R. J. Denman, W. Zhang, Chem. Soc. Rev. 2013, 42, 6634 – Accepted manuscript online: November 2, 2018
6654. Version of record online: January 14, 2019
Chem. Eur. J. 2019, 25, 4590 – 4647 www.chemeurj.org 4647 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim